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Abstract 
Neurodevelopmental polybrominated diphenyl ether exposures 
 
Robert Gregory Poston 
Doctor of Philosophy in Quantitative and Systems Biology 
University of California, Merced 
2019 
 
Humans around the world are exposed to many potentially toxic 
compounds of both natural and anthropogenic origin. Industrial chemicals 
represent a large fraction of such compounds, some of which are now 
considered widespread environmental pollutants. One such class of compounds 
is polybrominated diphenyl ethers (PBDEs), a widely prevalent persistent organic 
pollutant spread largely by anthropogenic production and use of these chemicals 
as flame retardants in consumer products. The lipophilic nature of PBDEs, which 
are small halogenated organic molecules, allows them to accumulate in lipid-rich 
bodily tissues, including the brain. Due to the exposure kinetics of these 
compounds (detailed in Chapter 4 of this dissertation), cortical astrocytes and 
neurons are likely exposed in a region-specific manner. Concerningly, there is 
now a growing body of evidence epidemiologically linking PBDE exposure levels 
and incidences of behavioral deficits related to neurodevelopmental disorders 
(NDDs) in human children. NDDs include intellectual disability, attention deficit 
disorders, and autism spectrum disorders that are estimated to affect 15-20% of 
children in the United States. This association is supported by evidence from 
non-human animal studies that has established that exposures to several PBDEs 
affect learning. In an effort to understand how exposures to these compounds is 
related to observed behavioral effects, several major mechanisms have been 
identified, including: disruption of calcium homeostasis, interference with 
hormonal signaling, cellular toxicity resulting from mitochondrial disruption and 
the production of reactive oxygen species, and a more recently emerging focus, 
disruption of epigenetic mechanisms. Despite much progress, there is not a clear 
understanding of how molecular and cellular effects of PBDE exposure are 
related to observed impacts on behavior and learning. In this dissertation, I first 
tested the hypothesis that the effects of neurodevelopmental PBDE exposures 
intersect with epigenetic regulators in embryonic cortical neurons, leading to the 
development and testing of a mechanistic hypothesis of intracellular signaling 
disruption caused by ortho-hydroxylated PBDE metabolites. I close by detailing a 
model of neurodevelopmental PBDE exposures that I combine with novel data 
generated here to generate hypotheses for future study. This body of work aims 
to be of value in continuing to build an understanding of the effects of PBDE 
exposures in the developing nervous system, how these exposures are related to 
observed behavioral deficits in animals, and generating insight regarding the 
interplay between genetic and environmental risk factors in neurodevelopmental 
disorders. 
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Chapter 1: Introduction – Polybrominated 
diphenyl ethers, epigenetic regulation, and 
neurodevelopmental disorders 
 
Across the world, humans face exposure to a vast number of industrial 
chemicals, whose potential for negatively impacting human health has long been 
a concern (Smyth 1946; Gehrmann 1946; Henry 1946). In early 2018, the United 
States Environmental Protection Agency (EPA) reported 30,972 active chemicals 
in industry out of a total of 86,071 registered in the agency’s Toxic Substances 
Control Act (TSCA) Chemical Substance Inventory. The European Chemicals 
Agency’s (ECHA) most recently updated figure from their relatively new 
Regulation for Registration, Evaluation, Authorization and Restriction of 
Chemicals (REACH) initiative reports 21,403 unique substances. China has also 
established a program recently—similar to Europe’s REACH regulations—that 
mandates new updating of China’s chemical inventory, the Inventory of Existing 
Chemical Substances (IECSC), which lists 45,612 substances as of 2013. As 
world governments attempt to define what chemicals have been produced and 
are in use, efficient methods to identify and evaluate compounds for safety 
screening are still being debated and formed. Progress is slow, with few 
chemicals actually being heavily regulated. In the US, the history of chemical 
regulation is long and convoluted, and is well reviewed elsewhere (Krimsky 
2017). Presently, the EPA is in the midst of a three-tiered evaluation program 
designed to assess the safety of existing chemicals, with only the most 
dangerous chemicals likely to ever reach the eventual ‘Risk Management’ phase. 
It is questionable whether this type of approach is practical at all, yet meaningful 
change may not come soon, as it is unlikely that the country will shift the burden 
of proof regarding chemical safety from regulatory agencies to manufacturers (as 
with Europe’s REACH program). In the meantime, the vast volume and diversity 
of industrial chemicals we expose ourselves to continues to pose a potentially 
serious risk to human health. There are numerous avenues by which hazardous 
compounds may impact human health, perhaps the most widely recognized of 
which are potential for carcinogenicity, adverse effects on reproductive health, 
and disruption of hormonal signaling. Another exceedingly concerning endpoint 
for human health is nervous system toxicity, particularly during development of 
the brain. The developing brain is an especially vulnerable target due to the 
complex nature of its formation and refinement that spans prenatal and years of 
postnatal development. As such, neurodevelopmental toxicity induced by 
chemical exposures has been heavily studied (Grandjean and Landrigan 2014), 
but much remains unclear. In the body of work presented here, I will focus on a 
class of industrial chemicals that has been under heavy scrutiny for suspected 
neurodevelopmental toxicity: polybrominated diphenyl ethers (PBDEs). 
 
PBDEs are a group of environmentally persistent chemicals that were first 
synthesized in 1871 by the German chemist Wilhelm Hoffmeister (Hofmeister 
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1871). In 1960, they were patented for use as flame retardants and subsequently 
have been widely used in household consumer products. Due to their 
environmental stability and propensity for bioaccumulation, PBDEs have since 
globally accumulated in the environment and in our bodies. Intriguingly, PBDEs 
enter the environment from natural sources in addition to industrial production. The 
compounds were first described in the biomedical literature as early as the 
1960s—around the very beginning of their heavy anthropogenic production and 
use—when they were isolated from Australian marine sponges (Dysidea sp.) and 
found to have antimicrobial properties (Sharma and Burkholder 1967; Burkholder 
and Sharma 1969; Sharma et al. 1970). They have also been isolated from various 
red algae (Malmvärn et al. 2008; Malmvärn et al. 2005). Recently, in the case of 
sponges, it was demonstrated that PBDEs are actually produced by symbiotic 
cyanobacteria and are theorized to confer some level of microbial resistance to the 
host sponges, although the mechanism(s) by which the compounds are toxic to 
other organisms remains unknown (Agarwal et al. 2017). It is interesting to note, 
however, that these compounds are excreted by the cyanobacteria and 
subsequently accumulate in high concentrations, crystalizing in the sponge 
ectosomal tissues. This is perhaps how sponges avoid the compounds’ toxic 
effects and how they may be a defense mechanism against potential eukaryotic 
predators such as fish in addition to other prokaryotes (Unson et al. 1994). In the 
context of human health, it is unfortunate that such a class of compounds, whose 
natural production was likely evolutionarily driven by their toxicity, ended up 
becoming a flame retardant of choice for consumer products. Understanding the 
natural origins of PBDEs may also inform our investigation of their biological 
effects in humans, which is of pressing importance given another unfortunate 
aspect of PBDE biology—the growing evidence for their epidemiological 
association with neurodevelopmental disorders (NDDs). In this chapter, I will 
discuss known biological mechanisms affected by PBDEs, focusing on 
epigenetic impairments and the impacts these disruptions may have on human 
health, especially in the context of neurodevelopmental disorders. 
1.1 Relation of PBDEs to Human Health 
1.1.1 Human Exposure to PBDEs and Effects on Human Health 
A major effort has been devoted to evaluating the potential risk of PBDE 
exposure to human health. For the sake of brevity, here I will highlight some of 
the major points while pointing to relevant reviews and meta-analyses of the vast 
number of studies that have been published on the topic. Monitoring of 
environmental and human levels of PBDEs in the 1990s led to a rising concern 
that they may pose a serious human health risk, a concern which became widely 
recognized by the early 2000s (Eriksson et al. 2001). At the time, the extent the 
of compounds’ toxicity was unclear despite increasing amounts of toxicological 
evidence. Following much attention in the time since, it is now clear that 
exposure to PBDEs is a very real concern for humans around the world as the 
compounds are environmentally stable and lipophilic, and thus tend to 
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bioaccumulate and also collect in households, primarily in dust. These routes of 
accumulation enable the most common modes of human exposure—primarily 
through ingestion and inhalation of dust (Frederiksen et al. 2009; Bramwell et al. 
2016) and dietary intake, predominantly from seafood and dairy products 
(Linares et al. 2015). It is also concerning and of interest that infants and toddlers 
tend to have higher body burdens compared to adults when considering potential 
developmental toxicity (U.S. Environmental Protection Agency (EPA) 2010). This 
is thought to be caused by younger children having higher rates of intake from 
dust and household products, as well as by additional exposure to PBDEs 
through breastmilk.  
 
Due to the persistent, widespread, and sometimes heavy exposure levels 
observed, much attention has been given to the roles of PBDEs in several major 
aspects of health: carcinogenicity, reproductive health, and disruption of 
hormonal signaling (Costa et al. 2008; Linares et al. 2015; Gorini et al. 2018). In 
addition to these concerning PBDE-related effects on human health, another 
serious worry is their neurotoxicity and potential roles in the etiology of 
neurodevelopmental disorders (NDDs). NDDs are a heterogeneous class of 
developmental disorders of the nervous system including autism spectrum 
disorders (ASD), attention deficit/hyperactivity disorder (ADHD), intellectual 
disability (ID), and schizophrenia. It is estimated that up to 15% of children in the 
United States are affected by such disorders (U.S. Environmental Protection 
Agency (EPA) 2015). Despite their growing prevalence, there remains much that 
is unknown regarding the etiologies of the disorders. With the continuing 
emergence of sequencing technologies, much effort and hope has been put into 
disentangling the complex origin of NDDs at the level of genetic 
mutation/variation, largely through whole-genome sequencing and whole-exome 
sequencing studies of affected individuals and their families (Jeste and 
Geschwind 2014; Cardoso et al. 2019). This effort has led to an understanding 
that complex networks of genetic mutations underlie NDDs, rather than most risk 
being account for by highly penetrant mutations as with Mendelian diseases 
(Parikshak et al. 2015; Hu et al. 2014). In addition, it has come to be increasingly 
appreciated that additional factors such as environmental exposures must also 
be accounted for to understand the complex risk interactions giving rise to NDDs 
(De Felice et al. 2015).  
 
A substantial amount of work has been done, surveying the potential 
association of PBDE exposures with representative behavioral deficits in 
humans, as well as in other animal models. Animals exposed to various PBDEs 
during prenatal and/or postnatal periods exhibit long-lasting behavioral 
abnormalities, including deficiencies in motor activity and cognitive functions 
(Eriksson et al. 2001; Gee and Moser 2008; Branchi et al. 2002; Dufault et al. 
2005). Along similar lines, epidemiological studies in human populations have 
reported significant associations of maternal neonatal PBDE exposure with 
deficits in motor behavior, Intelligence Quotient (IQ) ratings (showing intellectual 
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disability), and  attention and cognitive functions in children (Herbstman and Mall 
2015; Herbstman et al. 2010; Eskenazi et al. 2013; Chevrier et al. 2016; Cowell 
et al. 2015; Chen et al. 2014). Recently, an expert panel identified a 70-100% 
probability that exposure to PBDEs contributes to IQ loss and intellectual 
disability that cost the EU public an estimated €9.59 billion (Bellanger et al. 
2015). Among other relevant findings, a significant positive correlation has been 
established between concentration of PBDEs in postpartum breast milk and 
increased externalizing behavioral problems (Hoffman et al. 2012) (reminiscent 
of ADHD-like behavior in older children), as well as between PBDE concentration 
in peripheral or cord blood and increased risk of attention symptoms and poorer 
social competency scores (Gascon et al. 2011). Summarizing these and other 
studies, several large-scale and systematic reviews have recently been 
conducted, both of evidence from human (Vuong et al. 2018; Lam et al. 2017; 
National Academies of Sciences and Medicine 2017) and animal studies 
(Dorman et al. 2018). Briefly, they conclude that PBDE exposures highly 
correlate with externalizing behaviors and IQ in children, while BDE-47/99/209 
were specifically concluded to affect learning in animal studies. There is also 
concern for the relationship between environmental toxins such as PBDEs and 
autism spectrum disorders, although the relationship is less clear, especially in 
human studies (Ye et al. 2017). Given the established and suspected 
connections between PBDE exposures and intelligence and behavioral deficits, 
as well as other aspects of human health, it is imperative to strive for a 
mechanistic understanding of PBDE toxicity at the molecular and cellular level. 
 
1.2 Biological mechanisms of PBDE toxicity 
1.2.1 Known Mechanisms  
Since the rise of concern regarding PBDE toxicity, several major impacted 
biological mechanisms have been identified and investigated. These and other 
less explored effects of PBDEs have been recently reviewed (Costa et al. 2014). 
Briefly, major identified points of toxicity are: (1) disruption of calcium signaling—
dating back to one of the earliest functional studies of PBDEs (Bussau et al. 
1993) and more recently demonstrated in multiple cell types including human 
neuronal precursors (Dingemans et al. 2008; Gassmann et al. 2014); (2) 
interference with endocrine signaling—thought to be enabled by structural 
similarity to various hormones (Sueyoshi et al. 2014; Pacyniak et al. 2007; Wahl 
et al. 2010; Dingemans et al. 2011); (3) toxicity produced by mitochondrial 
disruptions including uncoupling of oxidative phosphorylation (van Boxtel et al. 
2008) and subsequent elevated production of reactive oxygen species (ROS) 
which can lead to DNA damage and apoptosis. Many of the details of these 
known effects remain unresolved and other unidentified mechanisms are likely 
also affected. Additionally, much of the information on these established effects 
is derived from experimental exposures to individual PBDEs, while there are 209 
congeners that humans are theoretically exposed to in mixtures, and these 
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compounds can be further processed to produce various metabolites. Such 
metabolism, thought to be initially endogenously mediated in humans by 
cytochrome P450 enzymes (Feo et al. 2013a; Erratico et al. 2013; Fu et al. 2016) 
and inherent in some other natural contexts (Agarwal et al. 2014; Agarwal et al. 
2017; Malmvärn et al. 2005; Malmvärn et al. 2008), leads to the production of 
hydroxylated and methoxylated forms that have received less attention thus far. It 
has additionally been shown that these oxygenated metabolites can be further 
modified, producing glucuronidated and sulfated forms (Erratico et al. 2015; 
Cisneros et al. 2019), for which there are no data available in terms of biological 
effects. Addressing this lack of information regarding PBDE metabolites is 
important given that human exposure studies suggest that several OH-PBDEs 
are present in serum at concentrations similar to, and sometimes higher than, 
Figure 1-1. PBDE exposures affect epigenetic regulatory mechanisms at 
multiple levels, across multiple biological systems. There are several major 
aspects of human health that are of concern regarding PBDE toxicity that now 
have evidence for an involvement of dysregulated epigenetic regulation. These 
include: nervous system toxicity, disruption of thyroid hormone signaling, 
effects on the reproductive system (primarily on the placenta and testes), and 
oncogenic potential. Epigenetic components are known to be disrupted in each 
of these systems. In this review, we discuss these epigenetic regulators, their 
known modes of disruption by PBDEs, and the relationship of these disruptions 
to human health. 
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those of parent PBDEs (Qiu et al. 2009; Athanasiadou et al. 2008) and that OH-
PBDEs appear to be more capable of competitively binding the thyroid hormone 
transporter transthyretin, potentially mediating increased endocrine-disruption 
(Meerts et al. 2000; Hamers et al. 2008; Hamers et al. 2006; Cao et al. 2010; 
Ren and Guo 2012). Other confounding factors include that past studies have 
covered a wide range of concentrations, many likely higher than environmentally 
relevant exposures, and much of this work has been conducted in cell culture, 
requiring further in vivo confirmation. Thus, while an extensive amount of work 
has been done, there is much that may yet be uncovered regarding biological 
mechanisms of PBDE toxicity. 
 
A growing approach towards understanding PBDE toxicity has focused on 
PBDE-induced disruption of epigenetic regulation (Figure 1). Such mechanisms 
are interesting as potential PBDE targets as they would constitute a gene-
environment interface for cellular disruption, wherein the effects of exposure to 
environmental factors interact with genomic elements, perhaps even with known 
genetic risk factors for human disease like NDDs (Tran and Miyake 2017). Such 
interactions could contribute towards explaining the elusive environmental portion 
of risk thought to contribute to NDD etiology. This notion is supported by the 
growing appreciation for the role of epigenetic mechanisms in neurodevelopment 
and cognition (Lasalle et al. 2013; Marshall and Bredy 2016), as well as in 
diseases of the nervous system, including neurodevelopmental disorders (Millan 
2013; Christopher et al. 2017). Therefore, it may prove useful to understand the 
effects of PBDE exposures on epigenetic components, across cell and tissues 
types but particularly in the brain, in order to build more complete causal models 
towards explaining observed links to human health complications and behavioral 
deficits. However, compared to other widely studied mechanisms, relatively little 
attention has been given to epigenetic effects of PBDEs. Here, I will summarize 
the findings of studies conducted to date that have observed epigenetic 
endpoints such as DNA methylation, chromatin characteristics including 
modifications and remodeling of histones, and other epigenetic mechanisms 
such as expression of various non-coding RNAs. 
1.2.2 Repeatedly Observed Disruption of DNA Methylation 
One of the most commonly recognized epigenetic mechanisms is DNA 
methylation. Methylation commonly occurs at cytosine nucleotides positioned 
before a guanosine (CpG dinucleotides), resulting in a 5-methylcytosine. Given 
the extensive impact methylation has on transcriptional regulation (Bird 2002), it 
comes as little surprise that its disruption has potential impacts on human health 
(Bergman and Cedar 2013). An interesting example is folate deficiency’s 
implication in disrupted methylation during pre-natal development, although the 
relationship is incompletely understood (Crider et al. 2012). The relationship 
between PBDE exposure and DNA methylation is similarly incompletely 
understood. Although most studies report some correlation, they do not have a 
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clear consensus, especially in human samples, while in vitro studies more 
consistently report negative correlations (see references below).  
 
Studies have assessed PBDE-exposure-dependent changes in global DNA 
methylation at various representative regions or at specific loci (gene promoters). 
Two of the most prominent examples of representative methylated regions 
include ALU elements and LINE1, which are common transposable repeats that 
can have adverse cellular impacts when de-repressed due to hypomethylation 
(Eden et al. 2003). Repetitive elements make up a large portion of the human 
genome (de Koning et al. 2011) and have high CpG frequency, contributing 
heavily to the global amount of DNA methylation and thereby serving as a 
reasonable global estimate.  
 
One of the earliest studies on the effects of PBDE exposure on global DNA 
methylation in humans found a negative relationship between measured BDE-47 
levels and ALU %5mC in blood samples of healthy Korean adults, while not 
finding significant relationships for BDE-99 or LINE1 methylation (Kim et al. 
2010). Similar studies correlating PBDE levels in blood with methylation have 
followed. One found an inverse relationship between BDE-47 abundance and 
TNFα promoter methylation in cord blood samples from mother–infant pairs of 
the Boston Birth Cohort (Dao et al. 2015). Another reports a more complex 
finding in newborn cord blood samples from the CHAMACOS study, wherein 
significant changes in LINE1 methylation were found when considering co-
exposure to DDT, DDE, and PBDEs (the direction of change depended on level 
of DDE or DDT co-exposure) (Huen et al. 2014). 
 
Several groups have also examined the relationship between PBDE levels 
and effects on the placental epigenome. In 2016, two reports were published on 
effects in human placental samples. In one, the authors made PBDE, PCB, DDE 
measurements in villous placental tissue samples and found positive 
associations of PBDE levels with IGF2/H19 imprinting and methylation status 
(bisulfite conversion and targeted pyrosequencing) and global DNA methylation 
(assessed by LUMA (luminometric methylation assay)) (Kappil et al. 2016). In the 
other, PBDE levels in umbilical cord blood were measured from eighty human 
samples and correlated with placental DNA methylation levels in LINE1, NR3C1, 
and IGF2. BDE-66/153/209 were all found to have significant negative 
correlations with methylation of some of these loci (Zhao et al. 2016). Two very 
recent reports have also been made utilizing in vitro models of the placenta. One 
group exposed primary villous cytotrophoblasts (CTBs, an in vitro model of 
human placental development) to BDE-47 or BDE-99. They found that BDE-47 
alters gene expression in a concentration-dependent manner and produced a 
low-level global increase in DNA methylation (assessed with 
HumanMethylation450 beadarray) (Robinson et al. 2019). Another group 
exposed human placental choriocarcinoma cells (BeWo cells) to 1μM BDE-47 
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and found reduced methylation of some CpG loci of mitochondrial biomarkers 
(with no differences found for 50 µMexposures) (Shan et al. 2019). 
 
In addition to these human studies, PBDE-methylation relationships have 
also been investigated in model animals—mostly rodents—both in vitro and in 
vivo. In vitro studies have been conducted in different cell types, but consistently 
found negative correlations between PBDE exposure and methylation level. In 
the earliest of these studies, primary hippocampal neurons were exposed to 
various concentrations of BDE-209 for 24 hours and subsequently, a global 
decrease in DNA methylation was found by an antibody based ‘ELISA-like’ assay 
(Chen et al. 2010). Another found decreased global DNA methylation after a 
10μM BDE-47 in murine N2A cells (assessed by HPLC and arbitrary primed 
PCR). This decrease coincided with increased adipocyte differentiation (2.5–25 
µM exposures) (Bastos Sales et al. 2013). In a related effort to understand how 
endocrine-disrupting chemicals may be inducing adipocyte differentiation, 
investigators report that BDE-47 induces demethylation of several sites in the 
PPARγ promoter (a key adipongenic transcription factor) in COS7 and 3T3-L1 
cells using Methylation-Sensitive High-Resolution Melting (MS-HRM) (Kamstra et 
al. 2014). Complementing these in vitro findings, in vivo studies that perinatally 
exposed rodents to BDE-47 reported interesting findings from offspring of various 
ages. These include decreased expression of LINE1 RNA (Suvorov and Takser 
2011), decreased methylation of Mt-co2, L1Rn, Bdnf, and Nr3c1 (Byun et al. 
2015), differentially methylated regions in sperm (Suvorov et al. 2018), and 
global DNA hypomethylation associated with behavioral deficits in both exposed 
wild-type and MeCP2-deficient female mice (Woods et al. 2012). Another study 
in mice assessing liver carcinoma tissue after DE-71 (a commercial mixture of 
PBDEs) exposure found little effect on global DNA methylation but reports a 
gene body methylation decrease in Tbx3 and subsequent mRNA and protein 
upregulation (Shimbo et al. 2017). While not directly assessing DNA methylation, 
a multigenerational study in zebrafish that exposed F0 animals to a PCB and 
PBDE mixture found disrupted behavior (hyper/hypoactivity) in F1–F4 larvae, as 
well as altered c-Fos expression (F1/2) and altered Dmnt3ba expression in all 
generations (Alfonso et al. 2019). 
 
To our knowledge, only two reports exist that found no relationship between 
PBDE exposure and DNA methylation levels of any targets measured in those 
studies. One found no detectable decrease in methylation at the p53 promoter 
after 24 hours of exposure to low micromolar doses (1, 5, 10 µmol/L) of BDE-47 
in human neuroblastoma cells (SH-SY5Y), although activation of the p53 
pathway in general was implicated in observed effects (Zhang et al. 2013b). The 
other found no significant relationship between BDE-47 serum levels and global 
methylation as assessed by the luminometric methylation assay (LUMA) in 
samples from an elderly Swedish population. However, significant relationships 
were established for other persistent organic pollutants including PCBs and the 
dioxin OCDD (Lind et al. 2013). Aside from these reports, the literature suggests 
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a fairly consistent—but not necessarily linear—relationship between PBDE 
exposures and DNA methylation levels. It is possible that changes may vary from 
genomic region to region and may not always manifest an altered phenotype. 
Also, there is scarce evidence concerning direct cause–effect relationships 
between methylation changes and behavioral phenotypes. To aid in filling this 
gap in knowledge, it may prove useful to further refine understanding of the route 
by which PBDEs affect DNA methylation states—be it primarily by dysregulation 
of DNA methyltransferase expression, cellular metabolism, intracellular signaling 
pathways, etc.  
1.2.3 Impact on Chromatin—Histone Modifications to Chromatin Remodeling 
Other reversible chemical modifications of chromatin include modifications to 
histone proteins that regulate chromatin structure and instruct remodeling 
processes, ultimately controlling gene expression (Venkatesh and Workman 
2015; Clapier et al. 2017). Studies starting as early as 2003 reported mixed 
results on PBDE-induced alterations of chromatin by several measures 
(chromosomal integrity, chromatin density and localization). Exposure of multiple 
bacterial strains to BDE-99 did not induce mutagenicity or a detectable increase 
in the number of structural chromosomal aberrations, while exposure to the PCB 
mixture Aroclor® 1254 did (Evandri et al. 2003). This early study explicitly stated 
that the possibility of PBDEs acting through epigenetic mechanisms could not be 
ruled out, which, in retrospect, was prudent foresight. Two subsequent studies 
have also reported no increase in degraded chromatin, both in sperm—the first in 
the sperm of mice orally exposed to BDE-209 (Tseng et al. 2006), the other in 
human samples of 153 men from the greater Montreal area, despite establishing 
a correlation between BDE-47 levels and decreased sperm concentration (Albert 
et al. 2018).  
 
However, there have also been a few studies that do report chromatin 
disruption following PBDE exposure. One study found that 24-hr nanomolar 
range exposures to several PBDEs (BDE-47/99/153/183/209) induced 
micronuclei formation during cytokinesis in MCF-7 cells, an indicator of 
chromosomal damage occurrence preceding cell division (Barber et al. 2006). It 
has also been found that rat pups exposed to a single injection of BDE-153 at 
post-natal day 10 (PND10) exhibited behavioral dysfunction in a dose- and age-
dependent manner one or two months later. Neurons in the CA3 region of the 
hippocampus of these rats were also found to be undergoing significantly 
increased rates of apoptosis, with chromatin condensed and localized to the 
nuclear membrane (Zhang et al. 2013a). Most recently, it was reported that BDE-
209 exposures reduced hESC differentiation (although total induction was still 
greater than 90%) and also led to chromosomal copy number variants (CNVs), 
as well as decreased expression of DNMT1/3A (Du et al. 2018). 
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There is also some evidence specifically for PBDE-induced dysregulation of 
histones and histone-regulating proteins. In an effort to understand the 
carcinogenic potential of BDE-209, the first such study found that HEK293T cells 
exposed to micromolar range levels of the toxin exhibited altered expression of 
chromatin-regulating genes, specifically a histone gene cluster that the authors 
hypothesize could affect nucleosome properties (Li et al. 2014). In the same 
year, another group reported that exposure of the marine madaka (Oryzias 
melastigma) to BDE-47 led to sex-specific differential protein expression in male 
and female gonads, with several histone variants (H2b, H3.3, H3a, H2a) being 
down-regulated in male gonads (Fong et al. 2014). Another study found that 
exposing maize (Zea mays L.) to BDE-47, and its metabolites 6-OH-BDE-47 and 
6-MeOH-BDE-47, led to elevated levels of ROS and phospho-H2AX, likely in 
response to DNA damage. Interestingly, the hydroxylated metabolite produced 
the most severe effects (Xu et al. 2015). Another study, primarily concerned with 
the relationship of PBDE exposure to reproductive health, exposed pregnant rats 
to BDE-47 from E8 to PND21. Male offspring were then assessed at PND120 for 
alterations in testes. It was found that exposed rats had smaller testes, 
decreased sperm production, and interestingly, an altered testes transcriptome 
and 4-fold decrease in protamine and transition gene expression (proteins 
responsible for histone-protamine exchange) (Khalil et al. 2017). Aside from 
these data that indicate potential disruptions of histone expression and 
nucleosome alteration, there are two studies that report PBDE-induced 
dysregulation of chromatin-regulating proteins. The first found that BDE-47 
treatment downregulated SirT1 expression (a histone deacetylase) in the livers of 
mice due to NAD(+)-depletion (Zhang et al. 2015).  
 
The potential importance of understanding the effects of PBDEs on 
chromatin dynamics cannot be understated given the fundamental importance of 
chromatin properties for regulating gene expression and thus cellular states. 
Going forward, it will be important for investigators to focus on identifying 
additional effects on chromatin while distinguishing those that are direct from 
indirect, hopefully allowing for elucidation of the underlying mechanism. 
1.2.4 Other Affected Epigenetic Mechanisms (Non-Coding RNAs) 
 
Non-coding RNAs—such as long non-coding RNA (lncRNA) and microRNA 
(miRNA)—can also act as epigenetic regulators (Rinn and Chang 2012; Cech 
and Steitz 2014). Various PBDE exposures have been reported to alter 
expression of miRNAs, and one study described effects on expression of liver 
lncRNAs. The earliest study assessing miRNA expression as an endpoint 
following PBDE exposure utilized placental samples collected from the National 
Children’s Study. Among other associations established for PCB and heavy 
metal exposures, the study reported a positive association between BDE-209 
and miR-188-5p expression and an inverse association for BDE-99 and let-7c (Li 
et al. 2015). Another group exposed hESCs in vitro to low doses of BDE-209 (1, 
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10, 100nM) for 4 days, inducing apoptosis and downregulating pluripotency 
genes, particularly OCT4, in part by hypermethylation of the promoter and 
induction of miR-145/335 which repress OCT4. There was also generation of 
ROS and decreased superoxide dismutase (SOD2) expression. ROS and OCT4 
effects were partially rescued by treatment with the antioxidant NAC (Du et al. 
2016). An even more recent study employing human cells found that, after 
stimulating THP-1 macrophages with BDE-209 and LDL, there was dose-
dependent repression of miRNA-21 which subsequently de-repressed toll-like 
receptor 4 expression (TLR4), enhancing TLR4-dependent lipid uptake (Zhi et al. 
2018; Zhi et al. 2019b; Zhi et al. 2019a).  
 
In addition to these examples in humans, two rodent studies concerning non-
coding RNAs in the liver have been published. The first found that BDE-47 
exposure upregulates CYP3A1 in rat liver and that this upregulation is mediated 
by BDE-47-induced repression of miRNA-23b, which negatively regulates 
CYP3A1 mRNA via a 3’ UTR binding site (Sun et al. 2016). The other study 
reported that conventional and gut-microbiome-depleted mice exhibit 
dysregulated lncRNA expression in liver tissue in response to both BDE-47 and 
BDE-99 exposure (Li and Cui 2018). Interestingly, BDE-47 has also been found 
to induce dysregulation of novel miRNAs in exposed zebrafish larvae. Of 
particular interest is miR-735, which may play essential roles in larval sensory 
development, explaining previously observed BDE-47-induced disruption of 
zebrafish visual perception (Zhao et al. 2017a). In the near future, a general 
model of PBDE-induced miRNA dysregulation may hopefully be established 
given the multiple intriguing examples already characterized. 
1.3 Summary 
Considering this growing body of work documenting epigenetic dysregulation 
induced by PBDE exposure, there appear to be several central lines of evidence 
emerging from research done in various health contexts, including: adipocyte 
differentiation and obesity, reproductive health—of both sperm/testes and the 
placenta, carcinogenicity (especially thyroid related), and negative impacts on 
nervous system formation and function. It is becoming clear that many, if not all, 
of these various aspects of human health are impacted by PBDE-induced 
disruption of normal epigenetic states and mechanisms. 
 
There are fairly consistent findings of a negative relationship between PBDE 
levels and DNA methylation from in vitro and non-human animal studies across 
varied cell/tissue types and methylation detection methods. However, the data 
from human samples is more difficult to interpret. Studies reporting effects on 
global DNA methylation levels inferred from representative regions have 
incongruent results, and evidence of alterations to methylation in the placenta 
are, likewise, not in direct agreement. However, this confoundment and the fact 
that human studies have so far been conducted across very different populations 
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and models should only encourage further work on the topic, especially given 
indications from non-human animal and in vitro studies. It will be of great value if 
these types of studies can build on the tentatively established negative impact of 
PBDEs on methylation and begin to focus on understanding the mechanisms 
underlying the alterations, while continuing to clarify effects in human studies. 
 
Compared to DNA methylation, the literature is sparser regarding the effects 
of PBDEs on other epigenetic mechanisms such as chromatin dynamics and 
expression of non-coding RNAs. However, some interesting ideas are beginning 
to emerge. While not yet well understood, PBDE-induced dysregulation of 
histones and chromatin regulators is an intriguing intersection for PBDEs and 
neurodevelopmental disorders, bolstered by the recent emergence of chromatin 
regulation as a major node of NDD risk (Lasalle et al. 2013; Gabriele et al. 2018). 
Further, it is tempting to speculate that epigenetic effects of PBDE exposure 
may, generally, turn out to be a point of convergence for environmental and 
genetic factors that contribute to NDDs. If the effects of these compounds on 
targets such as DNA methylation, chromatin components and regulators, and 
non-coding RNA expression (all of which are mechanisms known to have roles in 
neurodevelopment and perhaps NDD etiology) can be further explored and 
resolved, one or more could very well turn out to be that link. This is of pressing 
importance, especially for neurodevelopmental disorders considering their 
explosive increase in prevalence, growing evidence for the involvement of 
PBDEs in their etiology, and the long elusive role of environmental factors in 
these devastating conditions. 
 
A major challenge for epigenetic PBDE research will be to assimilate new 
findings into the existing framework of PBDE toxicity that has been established 
from insights into other major impacted biological mechanisms. It will also be 
important to carefully consider nuanced aspects of exposures including tissue 
and sub-cellular localization, conduct more research on environmentally relevant 
doses and mixtures of PBDEs, further explore the prevalence and effects of their 
metabolites, and, to the extent that it is possible, integrate evidence generated 
across human and non-human studies (both in vitro and in vivo). This will be 
necessary in order to construct a more holistic understanding of how these 
compounds impact cellular states and, ultimately, phenotypic outcomes. By 
moving towards such an understanding with continued research, we may 
eventually be able to explain how and to what extent these pervasive 
environmental pollutants are related to the numerous human health conditions 
that they appear to be contributing to and may perhaps gain additional insight 
into the nature of PBDE-related health complications themselves. 
 
With the emerging bodies of evidence for PBDE-induced epigenetic 
disruptions, epigenetic regulation (particularly chromatin remodeling) as a major 
node of risk in NDDs, and the growing evidence linking PBDE exposure levels 
with NDD-related behavioral abnormalities in humans and other animal models, 
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in my dissertation research I sought to characterize the cellular effects of PBDE 
exposures and related underlying molecular mechanisms in the developing brain. 
Specifically, I first tested the hypothesis that the effects of nanomolar range 
exposures to  BDE-47 and its hydroxylated metabolites interact with epigenetic 
regulation in neurons from the developing nervous system (Chapter 2), 
subsequently developed and tested a mechanistic hypothesis of synaptic 
disruption and intracellular signaling inhibition by ortho-hydroxylated PBDE 
metabolites (Chapter 3) based directly on findings generated from the data 
presented in Chapter 2– leading to an appreciation that hydroxylated PBDE 
metabolites likely affect multiple levels of cellular function by interfering with 
molecular processes in a sub-cellular-specific manner, and finally to the 
generation of several hypotheses integrating these new findings with each other 
and with data from the diverse biological fields surrounding PBDE neurotoxicity 
(Chapter 4).  
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Chapter 2: Persistent 6-OH-BDE-47 exposure 
impairs functional neuronal maturation and alters 
expression of neurodevelopmentally-relevant 
chromatin remodelers 
 
Robert G. Poston, Carissa J. Dunn, Pushpita Sarkar, Ramendra N. Saha 
Environmental Epigenetics 2018 
 
2.1 Abstract 
Polybrominated diphenyl ethers (PBDEs) are a pervasive class of brominated 
flame retardants that are present in the environment at particularly high levels, 
especially in the United States. Their environmental stability, propensity for 
bioaccumulation, and known potential for neurotoxicity has evoked interest 
regarding their effects on the developing nervous system. Exposure to PBDEs 
has been strongly associated with neurodevelopmental disorders. However, the 
details of their mechanistic roles in such disorders are incompletely understood. 
Here, we report the effects of one of the most prevalent congeners, BDE-47, and 
its hydroxylated metabolites on the maturation and function of embryonic rat 
cortical neurons. Prolonged exposure to 6-OH-BDE-47 produces the strongest 
effects amongst the parent BDE-47 congener and its tested hydroxylated 
metabolites. These effects include: i) disruption of transcriptional responses to 
neuronal activity, ii) dysregulation of multiple genes associated with 
neurodevelopmental disorders, and intriguingly, iii) altered expression of several 
subunits of the developmentally-relevant BAF (Brg1-associated factors) 
chromatin remodeling complex, including the key subunit BAF170. Taken 
together, our data indicate that persistent exposure to 6-OH-BDE-47 may 
interfere with neurodevelopmental chromatin remodeling mechanisms and gene 
transcription programs, which in turn are likely to interfere with downstream 
processes such as synapse development and overall functional maturity of 
neurons.  Results presented in this chapter have identified a novel aspect of 6-
OH-BDE-47 toxicity and open new avenues to explore the effects of a ubiquitous 
environmental toxin on epigenetic regulation of neuronal maturation and function.  
  
Keywords: neurodevelopment, BDE-47 exposure, Arc, activity-induced 
transcription, BAF complex  
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2.2 Introduction 
An increasingly studied point of convergence that may help to provide new 
insight on the relationship between the various effects of PBDE exposures and 
adverse behavioral outcomes is epigenetic regulation, specifically of gene 
transcription during neurodevelopment. Epigenetic mechanisms are a major 
driving force of normal neurodevelopment (Lasalle et al. 2013), and many 
neurodevelopmental complications involve dysregulation of gene transcription 
(Parikshak et al. 2015; Vissers et al. 2015). Although several epigenetic 
components of neurodevelopment are now well known, there remains much 
more to be characterized (Sweatt 2013), especially in regards to how they 
interact with environmental challenges like PBDE exposure.  
Epigenetic regulation refers to a range of processes (detailed more in the 
Chapter 1) including chemical modifications to DNA and histone proteins, non-
coding RNA expression, and ATP-dependent remodeling of chromatin structure. 
The latter is of particular interest in the context of NDDs, as it has recently 
emerged as a major node of risk including several highly penetrant mutations 
associated with the disorders (Gabriele et al. 2018). ATP-dependent chromatin 
remodeling is a process by which regulatory proteins restructure chromatin–the 
complex of DNA and proteins making up chromosomes in eukaryotic cells–a 
process that plays a major role in facilitating the vast diversity of cellular types 
and function produced from an organism’s genome (Ho and Crabtree 2010). The 
general mechanisms of how these regulators interact with DNA and 
histones/nucleosomes to modify their composition and structure is thought to be 
largely similar. However, the various canonical chromatin remodeling protein 
complexes are composed of many subunits and are regulated by various 
interacting proteins, including cell-type specific factors (Clapier et al. 2017).  
One such dynamically-regulated remodeling complex that is known to play 
critical roles in neurodevelopment is the BAF (Brg1-associated factors) complex 
(Staahl and Crabtree 2013; Sokpor et al. 2018). BAF complexes containing 
neuron-specific subunits are known to instruct neurodevelopment, especially the 
differentiation of neurons (Staahl and Crabtree 2013), as well as the regulation of 
synaptic formation, plasticity, and learning and memory (Vogel-Ciernia et al. 
2013; Zhang et al. 2016). Interestingly, mutations in chromatin remodelers, 
including BAF complex subunits, have recently been identified as NDD risk 
factors, establishing a major node of risk in the complex network of genetic 
factors now associated with NDDs (further details and references in Chapter 1).  
Considering this, we sought to explore the ways in which exposure to BDE-47 
and its hydroxylated metabolites influence the maturation and function of neurons 
from the developing nervous system, and screened for possible intersections 
with NDD risk at the level of transcriptional dysregulation by measuring 
expression of NDD candidate genes representing several of the major nodes of 
NDD risk (Vissers et al. 2015; Iakoucheva et al. 2019)– intracellular signaling 
molecules, synaptic proteins, and epigenetic regulators including several BAF 
complex subunits.   
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2.3 Materials and Methods  
 
2.3.1 Plasmids and sub-cloning 
 
A commercial shRNA construct for BAF170 (CCCAAACTGCTAGGGAAATTA) 
was obtained from Sigma. This shRNA sequence was inserted into pLKO.1-puro 
(designed by RNAi consortium or TRC; obtained from Addgene) and then 
packaged into lentiviruses. Self-inactivating HIV lentivirus particles were 
produced by transfecting 293T cells with the shRNA vector, envelope (pMD2.G; 
Addgene), and packaging plasmids (psPAX2; Addgene) using a previously 
described protocol(Saha et al. 2011). The BAF170 expression construct in a 
lentiviral backbone was a kind gift from Dr.  Trevor Archer (NIEHS, NIH)(Wade et 
al. 2016). BAF170 expression from this construct was validated by Western 
blotting. 
 
2.3.2 Dissociated neuronal culture, RNAi and cell treatment  
 
Cultures of cortical neurons were prepared from embryonic day 18 Sprague 
Dawley rats (UC Merced IACUC approval: AUP#13-0007 and AUP#16-0004). 
Dissociated cortical neurons were plated in Neurobasal medium (Invitrogen) 
supplemented with 25 μM glutamate (Sigma-Aldrich) and 0.5 mM L-glutamine 
(Sigma-Aldrich) and either B27 (Invitrogen) or NS21 and maintained in a similar 
medium without glutamate. NS21 was prepared in the laboratory as previously 
described (Chen et al. 2008). Neurons were routinely used for induction assays 
between 10–16 days in vitro. For infection with recombinant lentiviruses, the viral 
supernatant was diluted in neuronal media and cells were infected at a 
multiplicity of infection ranging from 2 to 5. To induce gene transcription under 
basal conditions using synaptic circuits, we co-treated neurons with 50μM 
Bicuculline (Sigma-Aldrich) and 75μM 4-Aminopyridine (Acros Organics) 
(Papadia et al. 2005). To induce gene transcription extra-synaptically, we 
blocked activity with 1μM TTX (Calbiochem) and induced the MAP-kinase 
pathways with 1μM phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich) 
(Schultz et al. 1997). BDE-47 and metabolites used to treat cultures were 
obtained from AccuStandard (BDE-047N, HBDE-4003N, HBDE-4004N, HBDE-
4005N).    
 
2.3.3 RNA extraction and gene transcription quantitation  
 
Total RNA was isolated from dissociated neurons using the GeneJET RNA 
Purification Kit (Thermo) with an off-column DNase (Promega) digestion. cDNA 
was synthesized using MuLV reverse transcriptase (Promega), random primers 
(Promega), oligo dTs (Promega), and RNase inhibitors (Thermo Scientific). 
Quantitative real-time PCR (qRT-PCR) was performed to quantify mRNA levels 
of specific transcripts using iTaq Universal Sybr Green Supermix (BioRad) and 
the BIO-RAD CFX Connect realtime PCR Detection System. Pre-mRNA levels 
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were estimated as previously described (Saha et al. 2011).  
 
2.3.4 Sample preparation for electrophoresis  
 
Neurons were lysed in ice-cold 1X RIPA buffer (25 mM Tris, pH 7.5, 150 mM 
NaCl, 1% Na- deoxycholate, 0.1% SDS, 0.1% NP-40) supplemented with 1:100 
protease inhibitor cocktail (Sigma-Aldrich-Aldrich). Lysed neurons were sheared 
by sonication (low setting; three cycles on Bioruptorâ), cell debris pelleted at 
15,000 rpm for 5 minutes at 4°C, and clarified supernatant transferred to pre-
chilled 1.5 mL microcentrifuge tube. Total cell extracts were denatured at 95°C, 
for 5 minutes, using either home-made 5X Laemmli buffer, 2X-, or 4X-Laemmli 
sample buffer (both from BIO-RAD).  
 
2.3.5 Western blotting and imaging  
 
Denatured protein samples were resolved on 4-20%- (BIO-RAD cat. no. 
4568095) or 4-15%- (BIO-RAD cat. no. 456-1083) Mini PROTEAN® gels in 
Tris/Glycine/SDS (BIO-RAD cat. no. 1610772). Resolved proteins were 
transferred onto LF PVDF membrane, using the BIO-RAD TBT RTA kit and 
protocol (cat. no. 1704272). PVDF membranes were incubated at 4°C overnight 
with appropriate primary antibodies in 1X TBS-T with 0.5% BSA at 1:1000 
dilution. Primary antibodies included the following antibodies: β-Actin 
(ThermoFisher Scientific AM4302), BAF170 (CST 12760), BAF155 (CST 11956), 
Brg1 (CST 49360), BAF47 (CST 91735). Next day, membranes were washed 
three times in 1X-TBST, probed with appropriate Alexa Fluor® secondary 
antibodies (Life Technologies) for 40 minutes at room temperature, washed three 
times with 1X TBS-T, and imaged using BIO-RAD Multiplex ChemiDocTM Imaging 
System.  
 
2.3.6 Immunocytochemistry and microscopy  
 
Antibodies for immunocytochemistry were used at dilutions between 1:100-1:500 
and include the following: NeuN (Millipore ABN78), Doublecortin (CST 4604S), 
Nestin (Invitrogen MA1-91657). Infected neurons were washed twice with 1X ice-
cold PBS (Fisher Sci). The cells were then incubated with 4% paraformaldehyde 
(Sigma-Aldrich) in 1X PBS for 15 minutes at room temperature and then washed 
twice with 1X PBS, permeabilized at room temperature for 20 minutes with 0.5% 
Triton X-100 (Fisher Sci), washed twice and blocked for 30 minutes with 10% 
goat serum (Gibco) in 1X PBS. Cells were incubated at 4°C overnight in 3% goat 
serum in 1X PBS with primary antibodies. Next day, primary antibody solution 
was removed and cells were washed thrice with 0.05% Tween (Fisher) in 1X 
PBS (0.05% PBS-T), and incubated with appropriate Alexa Fluor® secondary 
antibody (Lifetech) for 45 minutes, washed thrice with 0.05% PBS-T, cured 
overnight with Prolong Anti-Fade Gold with DAPI and imaged. Images were 
18 
 
captured with a Keyence BZ9000-E microscope at 40X magnification.  
 
2.3.7 Cell viability assay 
 
Cell viability was assessed by an MTT assay (Biotium) (Mosmann 1983) wherein 
mitochondrial activity is detected colorimetrically following incubation of cells with 
a tetrazolium salt. The assay was conducted according to manufacturer’s 
instruction, except that MTT incubation time was shortened to 30 min to avoid 
reaching a plateau where differences in product formation would be 
indistinguishable and reagent volumes were proportionally scaled up to 
appropriate amounts for 24-well plates. 
 
2.3.8 Statistics  
 
Error bars represent standard error of mean throughout this article. Statistical 
comparison of datasets was performed by one way ANOVA with Fisher’s LSD 
(Figure 2C and 6A) or by two way ANOVA with Tukey’s post hoc test (all other 
figures). Biological replicates are indicated throughout as N in corresponding 
figure legends. Biological replicates constitute cell culture preparations from 
independent dams. 
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2.4 Results 
 
2.4.1 Characterization of E18 primary rat neuronal cultures  
 
We dissected brain tissue from the pups of timed-pregnant Sprague-Dawley 
rats (Rattus norvegicus) on embryonic day 18 (E18) to obtain dissociated cortical 
neurons. Cells were then plated as monolayers in supplemented Neurobasal 
growth medium. The identity of these cultured cells was characterized over the 
first week of growth by immunocytochemistry (ICC) using antibodies raised 
against Nestin, DCX, and NeuN (neural progenitor, differentiating neuron, and 
differentiated neuronal markers, respectively (Frederiksen and McKay 1988; 
Gleeson et al. 1999; Mullen et al. 1992) (Fig. 1). The cultures were composed of 
Figure 2-1. Characterization of neuronal cultures across the first week of growth by 
immunocytochemistry. Rat cortical neurons were obtained by dissecting and dissociating 
cortices from E18 pup brains. Cultures derived from these cells were stained using antibodies 
against several markers of neuronal maturation: Nestin (neuronal precursor), DCX 
(differentiating neurons), and NeuN (differentiated neurons). Staining was conducted at 
indicated time points. Scale bar = 25µm. N=3  
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cells exhibiting expression of: Nestin and DCX on day 0 in vitro (DIV 0), 
predominantly DCX expression by DIV 4, and largely NeuN expression by DIV 7. 
Based on the expression of these markers, we identified our DIV 0 cells to be a 
mixture of both neuronal progenitors and differentiating neurons, whereas DIV 4 
and DIV 7 cells were predominantly differentiating and differentiated neurons 
respectively. Utilizing cultures of this nature allowed us to investigate the effects 
of exposure to BDE-47 and its hydroxylated metabolites across various early 
stages of neuronal maturation in vitro. 
 
2.4.2 6-OH-BDE-47 impairs neuronal maturation and activity-induced gene 
transcription 
 
Mature neurons sense environmental cues through neuronal activity and can 
respond via activity-induced gene transcription (Flavell and Greenberg 2008). 
Therefore, we sought to test the effects of PBDE exposure on functional 
maturation by conducting neuronal activity-induced gene transcription assays 
using a widely studied, neuron-specific immediate early gene (IEG), Arc, as a 
readout (referred to from here on as ‘activity-induced gene transcription assay’). 
Assays were conducted in cultures that were chronically exposed to 1µM of BDE-
47 or one of its hydroxylated metabolites– 3OH-BDE-47 (3OH), 5OH-BDE-47 
(5OH), and 6-OH-BDE-47 (6-OH) and neuronal activity was induced using 
Bicuculline and 4AP (Bic+4AP). Arc pre-mRNA, the direct output of transcription, 
was detected at fifteen minutes after induction and quantified by quantitative real-
time PCR (qRT-PCR) using intron-exon spanning primers. We found that 
transcription of Arc was significantly attenuated in cultures exposed to 6-OH from 
DIV 0-10, but not in cultures exposed to other compounds (Fig. 2B) suggesting 
that chronic exposure to 6-OH may interfere with functional maturation of 
neurons.  
Figure 2-2. (next page) Chronic 6OH exposure is detrimental to neuronal maturation and 
function. Activity induced Arc expression assays were conducted by treating cultures with Bic 
and 4AP for 15 min. (A) Timeline depicting PBDE exposure durations leading up to activity 
induction assays. Ten-day exposures were started either concurrently with plating (DIV 0) or 
after a week of growth (DIV 7) to assess differences in effect on differentiating versus 
differentiated neurons. (B) Induction of Arc after a 10-day exposure to 1µM BDE-47 or one of its 
hydroxylated metabolites, N=3. (C) Assessment of cell viability following 10 days of 1µM 6OH-
BDE-47 exposure. Viability was assessed colorimetrically by MTT assay. N=3. (D) 
Representative images of NeuN and DAPI stained cells on DIV 7 following treatment with 0.5µM 
6OH starting at DIV 0. Scale bar = 50µm (E) Quantification of NeuN and DAPI staining 
represented in D, (2, 562 untreated and 2, 634 6OH treated cells counted). (F) Representative 
western blot for Tuj1 (a marker of differentiated neurons) in cells exposed to 0.5µM 6-OH-BDE-
47 for seven days, N=3. (G) Induction of Arc after a ten-day exposure to various concentrations 
of 6OH, N=3. (H) Similar assay as shown in (G) except 6OH exposure was started on DIV 7, 
N=4. * P < 0.05, ** P < 0.01. ns = non-significant 
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Lack of functional maturation could be an inadvertent fallout of 6-OH-induced 
neurotoxicity or impaired neuronal differentiation. Any cytotoxicity in cells 
exposed to different doses of 6-OH was measured by MTT assay. This range of 
doses was selected based on an approximation of environmentally relevant 
exposures. The reasoning and justification for this approximation is detailed 
further in the discussion. While 1µM 6-OH was found to induce a significant 
reduction in cell viability after chronic exposure for ten days, 0.5 and 0.1µM 6-OH 
doses did not (Fig. 2C). Next, we studied effect of 6-OH on neuronal 
differentiation. 6-OH has been previously shown to inhibit differentiation at lower 
concentrations than its parent compound in adult neural progenitor cells and 
human neuronal precursors (Schreiber et al. 2010; Li et al. 2013). To verify any 
effect of 6-OH on neuronal differentiation in our system, we studied neuronal fate 
markers (NeuN and Tuj1) in DIV 7 neurons after prolonged exposure to the non-
cytotoxic 0.5µM 6-OH dose (Fig. 2D-F). On DIV 7, when neurons are 
differentiated in our system (Fig. 1), there was no difference in fraction of NeuN 
positive neurons between untreated and 6-OH treated cultures (Fig. 2D, E). 
Similar results were obtained with Tuj1, another marker for differentiated neurons 
(Fig. 2F), indicating that neurons can attain their fate and differentiate 
irrespective of exposure to 6-OH in our culture conditions. Therefore, reasons for 
6-OH exposure-related lack of functional maturation (Fig. 2B) likely lie 
elsewhere. 
 
Next, to explore any differences in 6-OH effects between differentiating and 
differentiated neurons, we conducted additional activity-induced gene 
transcription assays, exposing cells to a range of 6-OH concentrations from both 
DIV 0 and DIV 7. From these assays, a dose-dependent activity-induced Arc 
transcriptional response was observed in cultures exposed at both DIV 0 and DIV 
7 (Fig. 2G, 2H). Interestingly 0.5µM 6-OH exposure, which does not significantly 
affect cell viability, produced effects that were not statistically different from 1µM 
exposure. Taken together, these results indicate that chronic 6-OH exposure 
impairs functional neuronal maturation while differentially affecting cell viability 
depending on the exposure dose.  
 
2.4.3 6-OH-BDE-47 exposure impairs synaptic and extra-synaptic modules of 
activity-induced transcription 
 
Transcription of IEGs in response to neuronal activity relies on a cascade of 
intracellular components starting with functional synapses, then transduction of 
signals from the synapse to the nucleus, and finally chromatin accessibility in the 
nucleus itself (Matamales 2012; Saha and Dudek 2013). As Bic+4AP treatment 
induces neuronal activity by GABAergic disinhibition, any of these factors 
affected by 6-OH could be contributing to the decreased production of nascent 
Arc pre-mRNA in Figure 2. As such, results from Bic+4AP induction assays 
potentially reflect an accumulation of effects arising from dysregulation at any 
point from the synapse to the nucleus. Therefore, to more specifically test if 6-OH 
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was acting at synapses or further downstream, we induced Arc transcription 
intracellularly at the signal transduction level by stimulating the Mitogen Activated 
Protein Kinase (MAPK) pathway, which is known to transduce signals for rapid 
neuronal gene transcription (David Sweatt 2001; Chotiner et al. 2010). Our 
laboratory has established that neuronal rapid IEGs, including Arc (Saha et al. 
2011), may be induced extrasynaptically by activating the MAPK pathway with 
1µM of the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate 
(PMA) while blocking neuronal activity with 1µM tetrodotoxin (TTX), a potent 
sodium channel blocker (Fig. 3A) (Dunn et al. 2017). Using this extra-synaptic 
induction protocol, we found that Arc is induced within fifteen minutes. This Arc 
pre-mRNA induction was inhibited significantly by 1µM, but not 0.5µM or 0.1µM, 
Figure 2-3: Effects of 6OH exposure are at the 
synaptic and extrasynaptic levels and are not 
primarily mediated by disruption of thyroid 
hormone signaling. Activity induced Arc 
expression assays were conducted by treating 
cultures with Bic and 4AP or TTX and PMA for 15 
min after ten days of 6OH exposure starting at the 
time of plating. (A) Depiction of different modes of 
gene transcription assays. Note: Bicþ4AP 
induction (Fig. 2) is reliant on synaptic activity 
whereas TTXþPMA induction bypasses synapses 
and jumpstarts signaling cascades extra-
synaptically. (B) Timeline depicting 6OH 
exposures with or without addition of 
triiodothyronine (T3) followed by various activity 
induction assays. (C) Induction of Arc via direct 
activation of the MAPK pathway with PMA while 
blocking membrane activity with TTX in cultures 
exposed to various concentrations of 6OH N=5. 
(D) Induction of Arc with Bicþ4AP following 
exposure to 6OH with and without additions of T3 
to outcompete potential interactions of 6OH with 
thyroid hormone transporters and receptors N=3. 
*P < 0.05, **P < 0.01 
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6-OH exposure (Fig. 3C). Although 1µM 6-OH exposure caused a certain 
amount of cell death (Fig. 2C), the effect of the same dose seen in this assay 
may not be entirely due to neurotoxicity because the Arc induction values are 
normalized by an internal control (Gapdh, representing live cells). Additionally, 
comparing Fig. 2G and 3C, our data indicate that prolonged exposure to non-
lethal dose of 6-OH (0.5µM) may impair synaptic formation and/or functions 
(Bic+4AP assays; Fig. 2G), but spares extra-synaptic cascades of events that 
lead up to Arc transcription (TTX+PMA assays; Fig. 3C).  
 
One major suspected mode of action for PBDE toxicity is dysregulation of 
thyroid hormone homeostasis, including disruption of thyroid hormone levels, 
transport, and receptor activity (Costa et al. 2014). These effects are thought to 
be mediated by structural similarity between PBDEs and thyroid signaling 
molecules (Dingemans et al. 2011). To test if the observed effects of 6-OH in our 
assays are mediated primarily by disruption of intracellular thyroid signaling, 
cultures were co-exposed to 1µM 6-OH and either 30 or 3nM triiodothyronine 
(T3), which is present at low levels in culture media already. Elevated levels of T3 
were shown to rescue 10µM BDE-47-induced reduction of neuronal migration in 
another study(Schreiber et al. 2010). In our assays, elevated levels of T3 did not 
rescue 1µM 6-OH-induced attenuation of Arc induction following Bic+4AP 
stimulation, although the addition of 30nM T3 alone did significantly enhance 
induced Arc transcription (Fig. 3D). Together, these results indicate that elevated 
levels of thyroid hormone cannot rescue effects of 6-OH exposure, perhaps 
including its neurotoxic effects, opening the possibility of a thyroid-hormone 
pathway-independent mechanism of 6-OH toxicity. 
 
2.4.4 BDE-47 and its hydroxylated metabolites dysregulate expression of NDD 
candidate genes 
 
Observing that chronic exposure to 6-OH disrupts neuronal activity-related 
function in dosage-dependent manners, and that the effects are not primarily 
mediated by disruption of thyroid hormone homeostasis, we sought to identify 
other potential mechanisms. To accomplish this, we screened 15 NDD candidate 
genes, coding for proteins of various functions important for neuronal 
development and function (Table 1), for changes in mRNA levels following 
exposure to 1µM BDE-47 or its hydroxylated metabolites. Exposures were 
started at various time points to assess effects during neuronal differentiation. 
We found that exposure to BDE-47, 3OH, and 5OH altered mRNA levels of only 
a few genes, while 6-OH exposure altered mRNA levels of 11 out of 15 genes at 
the earliest and middle time points (exposures at DIV 0 and DIV 4), and a smaller 
subset when differentiated neurons were exposed starting at DIV 7 (Fig. 4). This 
observation suggests that 6-OH exposure may have temporally specific effects, 
with immature neurons being affected to a seemingly greater extent. Following 
up on the widespread effect caused by 6-OH, we measured mRNA levels of the  
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Gene Description/Function 
Associated 
Brain 
Disorders 
Adnp  
Activity-Dependent Neuroprotective Protein: zinc finger transcription factor that 
modulates p53 activity and interacts with BAF chromatin remodeling complexes 
to regulate transcription 
ASD, ID 
Arid1b  AT-Rich Interaction Domain 1B (BAF250b): DNA interacting protein, subunit of the neural precursor and neuron specific BAF chromatin remodeling complexes ASD, ID 
Cbx4 
Chromobox 4: component of a Polycomb group (PcG) PRC1-like complex which 
is involved in transcriptional repression of many genes throughout development 
and mediates monoubiquination of histone 2A lysine 119 residues 
ASD 
Ctnnb1  
Catenin Beta 1: component of the canonical Wnt signaling pathway, coactivator 
of TCF/LEF transcription factors that activate Wnt responsive genes which play 
diverse neurodevelopmental roles such as central nervous system patterning, 
and neural stem and precursor cell proliferation 
ASD, ID 
Dyrk1a  
Dual Specificity Tyrosine Phosphorylation-Regulated Kinase 1A: a nuclear 
protein kinase that catalyzes autophosphorylation of serine/threonine and 
tyrosine residues, thought to play a role in regulating signaling pathways 
contributing to cell proliferation and neurodevelopment 
ASD, ID 
Med13l  
Mediator Complex Subunit 13 Like: a subunit of the mediator complex, a 
transcriptional coactivator for RNA polymerase II transcribed genes that is 
recruited to promoters by binding with regulatory proteins thus serving as a 
scaffold for the preinitiation complex, involved in early neurodevelopment 
ASD, ID 
Ncor1  
Nuclear Receptor Corepressor 1: corepressor of thyroid-hormone and retinoic-
acid receptor target genes, known to recruit histone deacetylases that promote 
the formation of condensed chromatin structure that prevents access of 
transcription factors and thus represses transcription 
ASD, HD 
Npas2  
Neuronal PAS Domain Protein 2: transcription factor that is a core component of 
the circadian clock, also known to regulate the transcription of metabolism, cell 
cycle, and DNA repair related genes 
ASD 
Phf2  
PHD Finger Protein 2: a zinc-finger-like plant homeodomain containing 
demethylase that acts on both histone and non-histone proteins, dimerizes with 
Arid5b at target promoters and demethylates histone 3 lysine 9 (H3K9me2) 
residues leading to transcriptional activation 
ASD 
Rps6ka2  
Ribosomal Protein S6 Kinase A2: a member of the RSK family of 
serine/threonine kinases that phosphorylates members of the mitogen-activated 
protein kinase signalling pathway, regulates processes such as cell growth, 
survival, and proliferation 
ASD 
Shank3  
SH3 and Multiple Ankyrin Repeat Domains 3: major scaffold protein of the 
postsynaptic density that organizes neurotransmitter receptors, ion channels, 
and other membrane proteins via interactions with the actin cytoskeleton, plays a 
role in dendritic spine maturation as well as synaptic formation and plasticity 
ASD, ID, SCZ 
Smarcc2 
SWI/SNF Related, Matrix Associated, Actin Dependent Regulator of Chromatin 
Subfamily C Member 2 (BAF170): subunit of the neural precursor and neuron 
specific BAF chromatin remodeling complexes, thought to be a scaffolding 
subunit required for stabilization of other BAF subunits, involved in transcriptional 
activation and repression, known to regulate cortical thickness and neural 
progenitor proliferation 
ASD, SCZ 
Sp1  
Specificity Protein 1: a zinc finger transcription factor that binds GC-rich motifs at 
many promoters, involved in many cellular processes such as differentiation, 
growth, apoptosis, and recruitment of chromatin remodeling enzymes including 
Brg1 and Brg associated factors to regulate transcription 
ASD 
Tbl1xr1  
Transducin Beta Like 1 X-Linked Receptor 1: thought to be a component of the 
NCoR and HDAC3 repressive complexes, and is required for transcriptional 
activation by a variety of transcription factors 
ASD, ID 
Ubr3  
Ubiquitin-Protein Ligase E3-Alpha-3: targets proteins for degradation by 
ubiquinitination, may be involved in chromatin regulation and transcriptional 
silencing (by similarity) 
ASD 
Table 2-1. Neurodevelopmental disorder candidate genes screened for mRNA dysregulation 
following chronic exposure to BDE-47 or its hydroxylated metabolites; abbreviations: ASD- autism 
spectrum disorder, ID- intellectual disability, SCZ- schizophrenia, HD- Huntington’s disease 
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same 15 genes after exposure to a range of 6-OH concentrations over the 
various time points (Fig. 5). Dysregulation of mRNA levels by 6-OH was found to 
be dose-dependent, with transcripts of a few genes exhibiting significant changes 
at concentrations as low as 10nM (Arid1b, Tbl1xr1, and Adnp, data not shown). 
Of particular interest are Arid1b and Smarcc2, both of which code for subunits of 
the BAF chromatin remodeling complex (Ronan et al. 2013), as well as Shank3, 
a high confidence autism candidate gene whose protein product is involved in the 
organization of the postsynaptic density (Uchino and Waga 2013). In our screen, 
the high confidence autism candidate gene Shank3 was significantly 
dysregulated by 6-OH in an opposing manner depending on the time of exposure 
(Fig. 4, 5). Together, these screens demonstrate dysregulation of mRNA levels 
of several NDD candidate genes by chronic 6-OH exposure in a mammalian 
model, and further validate the dose- and time-of-exposure dependence of 6-OH 
toxicity. They also provide many potential novel targets for further investigation. 
 
While changes in mRNA levels following 6-OH exposure can be informative of 
altered cellular states, they do not necessarily indicate direct effects on the 
transcription of target genes. This is due to mRNA abundance being a function of 
the rate of transcription as well as of transcript decay, which can vary greatly 
(Garneau et al. 2007; Schoenberg and Maquat 2012). To verify if 6-OH-induced 
changes to mRNA levels were due to a direct effect on the transcription of target 
genes, we designed primers to detect pre-mRNAs, the short-lived, direct product 
of transcription by RNA polymerase II. We focused on genes strongly affected in 
differentiating neurons (cultures with exposure starting on DIV0) and measured  
Figure 2-4: Exposure to BDE-47 and its hydroxylated metabolites dysregulates mRNA levels of 
neurodevelopmental disorder candidate genes. 15 neurodevelopmental disorder-associated 
genes screened for changes in mRNA abundance by qRT-PCR following exposures to 1µM 
BDE-47 or one of its hydroxylated metabolites for periods indicated below each heatmap. Each 
row depicts changes in mRNA level for a gene while each column reflects exposure to a different 
compound. Results are displayed as fold change relative to control. Cells with a fold change 
above two have saturated coloring. * P < 0.05, ** P < 0.01. N=3–5 
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their respective pre-mRNA levels at time points within that window of exposure, 
where early neuronal differentiation is occurring (DIV0-5). Interestingly, as 
revealed by MTT assays and unlike what is seen in differentiated neurons (Fig. 
2C), 1µM 6-OH did not negatively impact cell viability by DIV3 (Fig. 6A). In these 
cells, as revealed by pre-mRNA assays, 6-OH exposure impacted most genes 
only at the mRNA level, perhaps via indirect mechanisms that influence mRNA 
half-lives. However, expression profiles of three of the tested genes were found 
to be significantly dysregulated at the pre-mRNA level – intriguingly, all of which 
encode BAF complex subunits or interacting proteins (Smarcc2, Arid1b, and 
Adnp). (Fig. 6B). 
 
2.4.5 6-OH-BDE-47 dysregulates expression of Smarcc2 (BAF170) and other 
BAF complex subunits 
 
One of the genes exhibiting 6-OH-induced changes in pre-mRNA level, 
Smarcc2, codes for BAF170, a core subunit of the mammalian SWI/SNF 
(SWItch/Sucrose Non-Fermentable)-like BAF complex. BAF complexes are ATP-
dependent chromatin remodelers that play important and fundamental roles in 
driving neurodevelopmental processes(Staahl and Crabtree 2013). BAF170 is 
thought to act as a scaffolding subunit that is critical for the stability of these  
Figure 2-5: Dysregulation of neurodevelopmental disorder candidate gene mRNA levels by 
6OH is dose- and time-of-exposure-dependent. 15 neurodevelopmental disorder-
associated genes screened for changes in mRNA abundance by qRT-PCR following 
exposures to various concentrations of 6OH for periods indicated below each heatmap. 
Each row depicts changes in mRNA level for a gene while each column reflects exposure 
to a different concentration of 6OH. Results are displayed as fold change relative to control. 
Cells with a fold change above two have saturated coloring. * P < 0.05, ** P < 0.01. N=3–4 
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complexes (Narayanan et al. 2015). Therefore, to test the effect of 6-OH on 
expression of other BAF subunits, we screened mRNA levels of other known 
subunits of the neuronal precursor and neuron specific BAF complexes 
(npBAF/nBAF) and found significant upregulation of several additional subunits, 
namely, Brm, Brg1, BAF60a, BAF53a, and BAF47 (Fig. 7A). Focusing on 
BAF170, we then sought to confirm 6-OH-induced dysregulation of this major 
BAF subunit at the protein level by Western blotting. Here, to our bewilderment, 
we encountered two opposing outcomes with almost equal frequency across 
replicates. In some trials, chronic exposure of differentiating neurons to 0.1-1μM 
6-OH downregulated BAF170 protein levels. In others, BAF170 protein levels 
were upregulated by the same treatment (Fig. 7B). Initially baffling, such 
vacillating outcomes may be explained if expression of BAF170 oscillates during 
neuronal differentiation and 6-OH exposure shifts the oscillation frame (Fig. 7B). 
This hypothesis is supported by previous work that found the expression of 
BAF170 to be very dynamic across mouse corticogenesis (Tuoc et al. 2013) and 
biphasic in H1 embryonic stem cells (Wade et al. 2016). To test this possibility, 
we collected samples at six-hour intervals after plating for the first 48 hours and 
then assessed BAF170 protein levels by western blotting. As shown in Fig. 7C 
(quantified in Fig. 7D), BAF170 levels were found to oscillate with time. Next, we 
attempted to quantify such oscillation with and without 6-OH exposure. To our 
Figure 2-6: Exposure to 6OH dysregulates pre-mRNA levels of a subset of genes affected 
at the mRNA level. (A) Assessment of cell viability following 3 days of exposure to 1µM 
6OH. Viability was assessed colorimetrically by an MTT assay. N=3. (B) A subset of 
neurodevelopmental disorder associated genes found to have dysregulated mRNA levels 
following 6OH exposure were screened for changes in pre-mRNA abundance which better 
reflect effects on transcription of a given gene. Time points within the earliest exposure 
period (DIV 0-7) were chosen to more clearly observe direct effects of 6OH toxicity. *P < 
0.05, **P < 0.01. N=3–7 
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surprise, these oscillations varied greatly between biological Ns, occluding any 
statistical analysis after averaging data from multiple trials. Despite such 
variations, 6-OH treatment consistently altered the oscillatory pattern in every N 
(5 attempted; three displayed in Fig. 7E), providing support to our ‘altered 
BAF170 oscillation’ hypothesis (Fig. 7B). 
 
Figure 2-7: BAF170 protein levels and mRNA levels of BAF complex subunits are dysregulated 
by 6OH exposure. (A) Abundance of various BAF protein mRNAs estimated by qRT-PCR 
following exposure to various concentrations of 6OH from DIV 0-7, N=3–4. (B) Top: BAF170 
protein levels observed by western blotting following 48 h of exposure to various concentrations 
of 6OH. N=6. Bottom: opposing outcomes can be explained if BAF170 is expressed in an 
oscillatory manner and 6OH exposures disrupt regulatory mechanisms shaping the temporal 
expression patterns. (C) Time-course western blot for BAF170 with samples collected every 6 h 
after plating for the first 48 h. (D) Quantification of BAF170 band intensities from blot shown in 
(C) as an example and evidence of BAF170 oscillation in normal cells. (E) Quantification of 
similar time-course experiments as in (C), with collections every 6 h starting 24 h after plating. 
Note the inherent variation in oscillatory pattern. Cells were either untreated or exposed to 1 
µM 6OH at the time of plating. N=4 (3 represented) *P < 0.05, **P < 0.01. Note: Because of 
inherent variation in the oscillatory pattern, averaging these data sets obscures the phenotype 
and is therefore not attempted. 
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2.4.6 Role of BAF170 in neuronal maturation and activity induced Arc 
transcription 
 
The BAF170 protein data above, alongside its altered pre-mRNA and mRNA 
levels, and the observed alterations to mRNA levels of other BAF subunits, 
indicate that 6-OH exposure likely influences BAF complex composition/stability 
and, therefore, potentially impacts BAF-dependent functions during neuronal 
differentiation, including chromatin remodeling and regulation of gene 
transcription. 
 
Finally, to directly study effects of BAF170 dysregulation on functional 
maturation of neurons, as would be expected due to 6-OH-induced oscillation, 
we bi-directionally altered its levels in early stage cells (DIV 0-4) by either 
overexpressing BAF170 or depleting it via RNAi (lentivirus-mediated delivery of 
BAF170 shRNA). Both methods were validated by western blot (Fig. 8D and 8G). 
We then performed synapse-dependent and synapse-independent Arc induction 
assays. The phenotypic outcomes of these assays were unaffected by 
overexpression of BAF170 (Fig. 8B and 8C). Interestingly, depletion of BAF170 
impaired Arc induction in the synapse-dependent Bic+4AP assay (Fig. 8E), but 
not in the synapse-independent PMA+TTX assay (Fig. 8F). This observation is 
reminiscent of the effects of lower 6-OH doses on Arc induction using these 
protocol (Fig. 2 and 3D). Additionally, we found that depletion of BAF170 
reduces protein levels of other BAF subunits (Fig. 8G). These observations 
support the idea that BAF170 acts as a scaffolding component in BAF complexes 
and indicates that dysregulation of BAF170 may effectively alter BAF complex 
stability and composition (Narayanan et al. 2015) (Fig. 7A). Interestingly, 
BAF155 protein levels did not decrease while other subunits, namely BAF60a 
and BAF47 whose mRNA levels were significantly upregulated following 6-OH 
exposure (Fig. 7A), exhibited reduced protein levels following loss of BAF170 by 
RNAi (Fig. 8G).   
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Taken together, our data suggest that BAF170 depletion, not its 
overexpression, likely impairs neuronal maturation via synapse-dependent 
mechanisms, but not extra-synaptic components of activity-induced gene 
transcription. As effects of BAF170-KD are highly evocative of the effects of 6-
OH exposure, we propose that environmentally-relevant doses of 6-OH may act 
via dysregulation of the BAF complex, especially BAF170, to interfere with 
neuronal maturation and function. 
 
  
Figure 2-8: BAF170 contributes to the stability of BAF subunits and proper circuit 
formation, but is not required for MAPK stimulated Arc transcription. (A) Depiction of the 
timing of lentiviral mediated manipulation of BAF170 levels and subsequent activity 
induced Arc induction assays. (B, C) Arc induction following Bic-4AP or TTX-PMA 
stimulation in cells overexpressing BAF170, N=3. (D) Representative western blot 
validating BAF170 overexpression construct. (E, F) Arc induction following Bic-4AP or TTX-
PMA stimulation in cells depleted of BAF170, N=3. (G) Representative western blots 
demonstrating the effect of BAF170 knockdown on protein levels of other BAF complex 
subunits, N=3. **P < 0.01. ns = non-significant 
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2.5 Discussion 
 
In this chapter, I have demonstrated several novel aspects of PBDE 
neurotoxicity. Initially, I show the effects of chronic nanomolar range exposures 
to BDE-47 and its hydroxylated metabolites on neuronal activity-induced gene 
transcription and functional maturation of primary embryonic rat cortical neurons. 
I then demonstrate how similar exposures impact transcription of NDD candidate 
genes by quantification of mRNA and pre-mRNA levels. One of the strongest 
candidates from our screen, Smarcc2, then prompted us to focus on the effects 
of 6-OH exposure on BAF170 expression and, preliminarily, on BAF170-related 
regulation of neuronal maturation by measuring levels of activity-induced Arc 
expression. Together, these results indicate that exposure to the hydroxylated 
BDE-47 metabolite 6-OH strongly influences functional maturation of neurons, 
potentially independent of thyroid hormone disruption mechanisms– perhaps 
instead exerting effects mediated in part at the level of epigenetic regulation via 
disruption of BAF chromatin remodeling complexes. 
 
Our utilization of the activity-induced transcription of an immediate early gene 
(Arc) as a readout of functional neuronal maturation is, to the best of our 
knowledge, a novel approach in assessing the neurotoxicity of PBDEs. 
Immediate early gene induction is a strong tool to this end as it relies on several 
critical cellular mechanisms that are established across neuronal maturation, 
ranging from proper synaptic function to nuclear regulation of gene transcription 
(Fig. 3A), allowing us to broadly assess the extent of PBDE-induced effects on 
functional neuronal maturation. Further, inducing Arc expression both 
synaptically (Bic+4AP) and extra-synaptically (TTX+PMA) allowed us to hone 
into where these neurotoxic effects are being exerted. These assays reveal that 
6-OH-BDE-47 interferes with neuronal maturation likely at the synaptic level. 
 
As mentioned previously, the range of PBDE doses used in this chapter were 
estimated based on prior work done in mammalian models to approximate 
relevant concentrations observed in the brains of exposed animals. To determine 
this range, an exhaustive review was conducted of literature reporting levels of 
BDE-47 accumulation in rodent brain following either chronic or single dose 
administration (Reistad et al. 2006; Staskal et al. 2006; Zhang et al. 2008; Ta et 
al. 2011; Koenig et al. 2012; Rasinger et al. 2014; Costa et al. 2015). After 
converting the commonly reported unit of ng/g of toxin to nmol/L (converting from 
lipid concentration to molarity), the average concentration of BDE-47 was 
determined to be 597nM. Studies investigating the in vitro effects of PBDEs have 
often been conducted using concentrations in the low to mid micromolar range. 
Summarizing human studies, the USEPA’s 2010 report assessing the 
environmental prevalence of PBDEs estimated the body burden of total PBDEs 
in the general population to be 30-100 ng/g (approximately 60 to 200nM), with 
toddlers tending to have higher body burdens compared to older children and 
adults. Importantly, BDE-47 alone was estimated to account for 50% of total 
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PBDE concentrations (U.S. Environmental Protection Agency (EPA) 2010). It has 
also been reported that hydroxylated metabolites of PBDEs accumulate in 
human serum and are nearly as abundant (approximately 45% of total detectable 
PBDEs) as parent PBDE compounds in human fetal blood samples collected in 
the United States (Athanasiadou et al. 2008; Qiu et al. 2009). Considering the 
reported brain accumulation levels of BDE-47 in rodents, concentrations 
commonly used for in vitro studies to date, and the prevalence of BDE-47 and its 
hydroxylated metabolites in humans, we used a range of 100-1,000nM BDE-47 
and its hydroxylated metabolites for our studies. This range spans reported 
accumulated concentrations in rodent brain, is low relative to previous in vitro 
studies, and is on the same order of magnitude as reported human levels of 
PBDEs and their metabolites. 
 
It has been previously demonstrated that micromolar BDE-47 exposures 
decrease both neuronal and oligodendrocyte differentiation in human neural 
progenitor cells (Schreiber et al. 2010). Another study found that BDE-47 and 6-
OH decrease neuronal and oligodendrocyte differentiation of mouse adult neural 
stem cells (aNSC), with 6-OH producing an effect following nanomolar 
exposures, at concentrations approximately 20 times lower than its parent 
compound (Li et al. 2013). Using activity-induced gene transcription assays as a 
readout in cultured embryonic rat cortical neurons, we found that chronic 
nanomolar exposure to 6-OH disrupts functional maturation. These effects were 
found to be independent of 6-OH cytotoxicity or alteration of differentiation for 
0.5μM exposures. Many of the observed effects were found to be dose-
dependent whereas transcriptional profiles (Fig. 4 and 5) were additionally 
sensitive to time of exposure. 
 
Additionally, these functional effects appear to be mediated at both synaptic 
and extra-synaptic levels, as evidenced by decreases in Arc induction following 
Bic+4AP and TTX+PMA treatments. Effects on IEG transcription by both assays 
indicate that 6-OH, at higher doses, may act to compromise cell viability, disrupt 
mature synapse formation, as well as interfere with cellular mechanisms at or 
downstream of the MAPK pathway that regulate activity-induced Arc transcription 
(Fig. 2 and 3). Interestingly, addition of excess levels of the thyroid hormone 
triiodothyronine (T3) did not produce any phenotypic rescue (as seen previously 
for BDE-47 induced impairment of neuronal migration (Schreiber et al. 2010)) of 
the observed attenuation of Arc induction. This advocates for additional modes of 
PBDE toxicity, perhaps acting alongside disruption of thyroid hormone signaling. 
However, we also note that 1μM 6-OH-induced cytotoxicity partially confounds 
interpretation of this attempted T3 rescue, as reduction of overall cell viability 
may obscure potential reversal of the effects of 6-OH exposure by T3. To explore 
alternate modes of PBDE toxicity within a context of the relation of PBDE 
exposure to NDDs, we screened 15 NDD candidate genes, many of which are 
epigenetic regulators (Table 1), for changes in mRNA level. Subsequently, we 
found that, while exposure to the parent compound and its other hydroxylated 
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metabolites significantly impacted only a few of these targets, 6-OH dysregulated 
mRNA levels of many of the screened genes. These included Shanks3, which 
encodes an important synaptic protein, supporting our inference related to 
detrimental synaptic effects of persistent 6-OH exposure. 
 
Of the genes dysregulated by 6-OH exposure, a smaller subset additionally 
exhibited altered levels of pre-mRNA, indicating a direct effect of 6-OH on 
transcription of these genes. Surprisingly, each of the genes whose pre-mRNA 
was found to be significantly dysregulated encode BAF chromatin remodeling 
complex subunits or interacting proteins (Adnp, Arid1b, Smarcc2). One of these 
genes, Smarcc2, encodes a critical core subunit known to contribute to overall 
BAF complex stability and composition, BAF170. Protein levels of BAF170 were 
subsequently found to be dysregulated by 6-OH exposure, though in a complex 
oscillatory manner that remains to be fully characterized. It may be the case that 
as lack of BAF170, but not overabundance, is detrimental for neurons (as we 
have shown in Figure 8), the cells are responding to repeated periods of lack of 
sufficient BAF170 by upregulating Smarcc2, while protein levels vary due to post-
translational regulation.  
 
BAF170 is a striking candidate whose dysregulation may contribute to the 
observed effects of 6-OH toxicity, owing to its critical contribution to BAF complex 
function. It has been shown to regulate the stability of BAF chromatin remodeling 
complexes by acting as a scaffolding subunit and preventing degradation of other 
BAF proteins. Our results support this notion and demonstrate a reduction of 
protein levels of several BAF subunits upon BAF170-KD (Fig. 8G), an effect 
previously only seen with removal of both BAF170 and another interchangeable 
complex subunit, BAF155 (Narayanan et al. 2015). This may indicate that 
BAF170 plays a larger role in stabilizing BAF complexes or specific subunits 
during the periods of neuronal maturation investigated in this chapter. This 
stabilizing aspect of BAF170 function, making it critical for BAF complex function 
as a whole, is intriguing as BAF complexes have well known roles in neuronal 
differentiation and maturation (Ronan et al. 2013), and are thought to contribute 
to regulating activity-induced gene transcription (Stunkard and Ghosh 2008; 
Zhang et al. 2016; Lyons and West 2011). As such, periods of 6-OH induced lack 
of BAF170 during early stages where differentiation and maturation taking place 
in our cultures may compromise the functional maturation of cells, leading to the 
observed decrease in Arc expression when assayed at later time-points.   
 
Accordingly, we have shown that reduction of BAF170 levels by RNAi, but not 
its overexpression, negatively impacts neuronal maturation using Arc induction 
as a readout, recapitulating the effect of exposure to 0.5μM 6-OH following 
Bic+4AP treatment. The lack of effect seen after BAF170 depletion on extra-
synaptically induced Arc (TTX-PMA protocol), as was the case with lower doses 
of 6-OH in Figure 3C, indicates that BAF170-containing BAF complexes may not 
be necessary for nuclear regulation of activity-induced Arc transcription within the 
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first 15 minutes after the onset of activity, but most likely contribute to synapse 
maturation and function via transcriptional regulation of other genes. These 
findings are consistent with recent evidence supporting the idea that BAF 
complexes are crucial for synapse formation and maturation during early 
neuronal development (Zhang et al. 2016). The same study implicated a role of 
Brg1, a core BAF complex ATPase, in activity-induced gene transcription six 
hours after onset of activity. However, as our data indicate, BAF170-containing 
BAF complexes are not specifically required for Arc induction at early time points 
if activity is induced extra-synaptically, likely owing to its poised transcriptional 
status (Saha et al. 2011). This lack of effect following BAF170 depletion and 
TTX+PMA treatment may be gene-specific as various IEGs are regulated in 
differing manners (Lyons and West 2011; Flavell and Greenberg 2008; Saha et 
al. 2011). 
 
While our current work potentially opens new avenues to explore the effects 
imposed by hydroxylated BDE-47 metabolites on epigenetic regulation during 
neuronal maturation and activity-induced gene expression, there are limitations 
to the experimental work in this chapter. Although we have demonstrated that 
exposure to 6-OH has a strong effect on BAF170 expression, from the pre-
mRNA to protein level, the effect is of a complex nature, whose mechanistic 
basis we do not yet fully understand. Consistent with our findings, the multiphasic 
expression pattern of BAF170 has been previously demonstrated during 
corticogenesis in mice (Tuoc et al. 2013) and in H1 embryonic stem cells (Wade 
et al. 2016), but further investigation will be required to fully characterize the 
expression profile of BAF170 and regulatory mechanisms that shape it. 
Additionally, like much PBDE research, we have investigated the effects of 
exposure to a single toxin at a time, while the developing human nervous system 
is realistically exposed to complex mixtures of pollutants. Some studies have 
been completed demonstrating effects of coexposures to environmental 
pollutants both in vitro and in vivo using combinations of PBDE congeners, other 
toxins including polychlorinated biphenyls (PCBs), and commercially available 
mixtures such as DE-71 (Pellacani et al. 2009; Tagliaferri et al. 2010; Miller et al. 
2012; He et al. 2011). More such studies will be needed to address the effects 
resulting from environmentally relevant mixtures of compounds, especially with 
concern to their metabolites. 
 
Finally, our results show that nanomolar range exposures to the BDE-47 
hydroxylated metabolite 6-OH strongly impact several aspects of neuronal 
maturation and function and that these effects are likely, at least in part, 
mediated by disruption of BAF chromatin remodeling complexes via 
dysregulation of BAF170 expression. Going forward, it will be important to fully 
characterize the regulatory mechanisms governing the intricate expression of 
BAF170 to discern precisely how the observed PBDE-induced dysregulation is 
produced. Additional investigation of the underlying mechanisms that mediate the 
neurotoxic effects of PBDE at the level of epigenetic regulation may lead to a 
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better understanding of how exposure to these compounds leads to 
developmental complications and NDDs as well as to further characterization of 
fundamental neuroepigenetic processes.  
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Chapter 3: Specific ortho-hydroxylated 
brominated ethers inhibit neuronal MEK-ERK 
signaling and disrupt neurodevelopmental 
processes 
 
In preparation: Robert G. Poston, Lillian Murphy, Ayna Rejepova, Mina Ghaninejad-
Esfahani, Joshua Segales, Kimberly Mulligan, Ramendra N. Saha 
 
3.1 Abstract 
 
 The developing nervous system is remarkably sensitive to environmental 
signals, including disruptive toxins, such as Polybrominated diphenyl ethers 
(PBDEs). PBDEs are an environmentally pervasive class of brominated flame 
retardants whose association with behavioral deficits in humans remains 
mechanistically unresolved. Using dissociated cortical neurons from embryonic 
rats (Rattus norvegicus), we found that chronic exposure to 6-OH-BDE-47, one 
of the most prevalent hydroxylated PBDE metabolites, suppressed both 
spontaneous and evoked electrical activity. Based on our previous work on MEK-
ERK biology and our observation that 6-OH-BDE-47 shares key structural 
similarities to Type-III non-ATP competitive MAP kinase MEK1 inhibitors, we 
hypothesized that certain hydroxylated PBDEs mediate neurotoxicity, at least in 
part, by inhibiting the MEK-ERK axis of MAPK signal transduction. We tested this 
hypothesis on three platforms: 1) in silico, where modeling ligand-protein docking 
revealed that the MEK1 inhibitor (PD-0325901) and 6-OH-BDE-47 docks to 
MEK1 at the same binding site, 2) in vitro in dissociated neurons, where MEK1 
inhibitor and 6-OH-BDE-47 — but not other hydroxylated BDE metabolites — 
similarly impaired MEK1-dependent phosphorylation of ERK1/2 and activity-
induced transcription of a neuronal immediate early gene, and 3) in vivo in 
Drosophila melanogaster, where developmental exposure to either the MEK1 
inhibitor or 6-OH-BDE-47 resulted in offspring displaying similar increased 
frequency of mushroom body β-lobe midline crossing, a metric of axonal 
guidance. Taken together, our data supports a novel toxicity mechanism for 
certain ortho-hydroxylated PBDE metabolites, which can inhibit MEK-ERK 
signaling and cause disruptions of critical neurodevelopmental processes, 
including spontaneous and evoked electrical activity, synaptic functions, and 
axonal guidance. 
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3.2 Introduction 
 
Previously, we utilized the ability of neurons to induce gene transcription in 
response to elevated network activity as a tool for assessing developmental 
PBDE toxicity (Poston et al. 2018). Specifically, we assayed levels of the neuron-
specific activity-induced immediate early gene (IEG) Arc after exposing 
embryonic cortical neurons across various stages of differentiation and 
maturation. Our rationale for employing this endpoint was that Arc induction 
relies on multiple levels of regulation, from electrical activity and synaptic 
function, to intracellular signaling (particularly Ca2+-dependent mechanisms), to 
nuclear regulation of gene expression — all of which are critical processes 
intertwined in regulating neurodevelopment (Spitzer 2006). These processes are 
largely hardwired by genetic programs but are also modulated by environmental 
cues. Exposure to toxins like PBDEs represent an environmental challenge that 
may dysregulate these processes at multiple levels, the cumulative effects of 
which could be detected as altered transcriptional responses. Results from the 
previous chapter showed that chronic exposures to a hydroxylated metabolite of 
BDE-47, 6-OH-BDE-47 (6-OH), dysregulate basal and activity-dependent 
neuronal transcription. Among those findings were data which strongly indicated 
that the attenuated transcriptional response following 6-OH exposure was 
mediated by synaptic dysfunction, and that 6-OH is capable of inhibiting 
intracellular signaling. Either could explain the attenuated transcription of Arc, as 
its activity-induced transcription relies on synaptic activity as well as signaling via 
the Mitogen Activated Protein Kinase (MAPK) cascade, one of the major 
signaling pathways that is important for neuronal plasticity (Thomas and Huganir 
2004) and, as we have recently shown, is necessary for Arc induction (Tyssowski 
et al. 2018). 
 
In this chapter, I propose and test a novel mechanism of PBDE metabolite 
toxicity: via inhibition of a kinase in the MAPK signaling pathway. The notion that 
a PBDE metabolite could have the capacity to inhibit MAPK signaling was of 
particular interest to us for several reasons. The MAPK pathway is a deeply 
evolutionary conserved intracellular signaling mechanism that supports diverse 
processes in both prokaryotes and eukaryotes (Pérez et al. 2008; Pereira et al. 
2011; Widmann et al. 1999). In prokaryotes, PBDE inhibition of MAPK-related 
serine/threonine kinases could explain the natural biogenesis of these 
compounds, known to have antimicrobial activity and to be produced by bacteria 
in several marine contexts, including sponge-cyanobacterial symbiotic 
relationships (Sharma and Burkholder 1967; Burkholder and Sharma 1969; 
Sharma et al. 1970; Unson et al. 1994; Malmvärn et al. 2005; Malmvärn et al. 
2008; Agarwal et al. 2014; Agarwal et al. 2017). In eukaryotes, the most well-
known role of MAPK is regulation of cell growth, division, and differentiation in 
many cell types, including stem cells in the developing nervous system (Zhang 
and Lie 2002; Li et al. 2006; Rhim et al. 2016). It is also known to regulate axonal 
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guidance and growth which has been demonstrated in multiple species (Bülow et 
al. 2004; Tang and Kalil 2005; Xing et al. 2016; Igarashi and Okuda 2019). 
Additionally, genetic syndromes involving the dysregulation of the MAPK 
pathway, known as the ‘RASopathies,’ are known to be involved in certain NDDs 
(Rauen 2013; Millan 2013). In mature neurons – post-mitotic non-dividing cells – 
the pathway regulates synaptogenesis (Huang and Reichardt 2001; Giachello et 
al. 2010), synaptic plasticity (Martin et al. 1997), activity-induced gene expression 
(Lyons and West 2011; Tyssowski et al. 2018), and generally, communicates 
information to a large number of cellular substrates. These roles in neural cells 
make MAPK signaling a concerning target for environmental disruption. 
However, the MAPK pathway remains largely unexplored as a target for 
pollutants. 
 
With these factors in mind, we sought to expand and clarify our previous 
findings with the studies reported here. Here, we show that chronic 6-OH 
exposure suppresses neuronal electrical activity and that acute exposures can 
inhibit MEK-ERK signaling, a crucial signaling cascade that couples neuronal 
activity with activity-dependent processes including gene transcription. We also 
report that in vivo exposures to 6-OH mimic exposure to the MEK inhibitor 
PD0325901 and similarly alter axonal guidance in the mushroom bodies of D. 
melanogaster. These new findings corroborate our earlier work and further 
demonstrate the ability of hydroxylated PBDE metabolites to disrupt 
neurodevelopmental processes via a novel mechanism. 
3.3 Materials and Methods 
 
3.3.1 Primary neuronal culture and cell treatment 
 
Primary cultures of cortical neurons were prepared from embryonic day 18 
Sprague Dawley rats (Charles River) (UC Merced IACUC approval: AUP#16-
0004). Isolated cortical hemispheres were collected in magnesium and calcium-
containing HBSS and mechanically dissociated by pipetting with a fire-polished 
Pasteur pipet following a short digestion with StemPro® Accutase® (LifeTech, 
A1110501). Dissociated cortical neurons were then pelleted by centrifugation, 
resuspended in plating media, counted using trypan blue and a TC20TM 
automated cell counter (BIO-RAD, #1450102), and subsequently plated by 
addition to dishes containing pre-warmed Neurobasal medium (Invitrogen) 
supplemented with 25 μM glutamate (Sigma-Aldrich), 0.5 mM L-glutamine 
(Sigma-Aldrich), and 2% NS21 supplement. Cells were maintained in the same 
medium without glutamate, exchanging half the conditioned media with fresh 
every 3-4 days. NS21 was prepared in the laboratory as previously described 
(Chen et al. 2008). Neurons were routinely used for various assays between 10–
14 days in vitro. To induce MEK-ERK signaling and gene transcription using 
synaptic activity, neurons were co-treated with 50 or 5μM Bicuculline (Sigma-
Aldrich) with or without 75μM 4-Aminopyridine (Acros Organics). To induce gene 
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transcription extra-synaptically, we blocked activity with 1μM TTX (Calbiochem) 
and induced the MAPK pathways via PKC with 1μM-1nM phorbol 12-myristate 
13-acetate (PMA; Sigma-Aldrich). BDE-47 and hydroxylated BDE metabolites 
used to treat cultures were obtained from AccuStandard (BDE-047N, HBDE-
4003N, HBDE-4004N, HBDE-4005N) and initially dissolved in dimethylsulfoxide 
(DMSO) at 2mM stock concentrations. Final treatment concentrations were 
produced at the time of treatment by dilution in culture medium. PD0325901 was 
obtained from AdipoGen (SYN-1059) and dissolved in DMSO at 5mM and 
similarly diluted at the time of treatment.  
 
3.3.2 Microelectrode array recording and data processing 
 
Neurons from the preparations described above were plated on poly-L-
lysine/laminin coated MEAs (60MEA200/30-Ti, Multi Channel Systems (MCS), 
Reutlingen, Germany) in 500 μl of the NS21-supplemented Neurobasal plating 
medium described above. When cells were fed, again every 3-4 days, 
approximately half the media was replaced with NS21-supplemented BrainPhys 
feeding media (StemCell). This was done to promote optimal conditions for 
neuronal firing which has been shown to be enhanced in BrainPhys media 
(Bardy et al. 2015). Recordings were made by placing arrays in an amplifier 
headstage that interfaces with MCS provided Multi Channel Experimenter 
software. Sampling was conducted at 10-20kHz in 3-minute sessions at room 
temperature (arrays were covered to prevent contamination). Recording were 
post-processed in Multi Channel Analyzer with a high-pass 1st order Butterworth 
filter with 100hz cutoff prior to quantification of spike number, determined by an 
automatic threshold estimator set to 6-8 standard deviations from the baseline 
signal. To quantify burst properties, the Multi Channel Analyzer burst detection 
tool was used with the following settings: max. interval to start burst, 25ms; max. 
interval to end burst, 250ms; min. interval between bursts, 1500ms; min duration 
of burst, 50ms; min. number of spikes in burst, 5. Raster images from example 
recordings were generated in NeuroExplorer (NexTechnologies, Herdon, VA). 
 
3.3.3 Ligand-Protein docking simulations 
 
For ligand-protein docking simulations, we used AutoDock Vina, an open-source 
molecular docking program made available through the Scripps Research 
Institute (Trott and Olson 2010). Initially, blind-docking of 6-OH-BDE-47 and 
PD0325901 was conducted with large areas of a published crystal structure of 
human MEK1 (PDB ID: 3EQI, Fischmann et al. 2009). Subsequent simulations 
searching a smaller grid-space centered around the catalytic binding domain 
were then conducted. The simulations were run with standard parameters for a 
rigid receptor and ligands with rotable bonds (Forli et al. 2016). The binding 
structures were evaluated based on comparison to the well characterized binding 
modes of allosteric MEK inhibitors, the first example of which was published in 
2004 (Ohren et al. 2004). 
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3.3.4 Western blotting and imaging 
 
Neurons were lysed in ice-cold 1X RIPA buffer (25 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 1% Na- deoxycholate, 0.1% SDS, 0.1% NP-40) supplemented with 1:100 
protease inhibitor cocktail (Sigma-Aldrich-Aldrich). Nuclear lysates were prepared 
by first washing cells with ice-cold 1X PBS, applying Plasma Membrane Lysis 
Buffer (PMLB) (25 mM Tris-HCl, pH 7.6, 10mM KCl, 1.5mM MgCl2, 0.5mM DTT, 
0.1% NP-40) for 1 min on ice, washing with PMLB, and then collecting in 1X 
RIPA buffer (pH 7.4). Lysates were sheared by sonication (low setting; three 
cycles on Bioruptorâ), cell debris pelleted at 15,000 rpm for 5 minutes at 4°C, 
and clarified supernatant transferred to pre-chilled 1.5 mL microcentrifuge tube. 
Synaptosomal isolations were prepared using Syn-Per according to manufacturer 
instructions (ThermoFisher). The various cell extracts were denatured at 95°C, 
for 5 minutes, using either 2X-, or 4X-Laemmli sample buffer (BIO-RAD). 
Denatured protein samples were resolved on 4-20%- (BIO-RAD cat. no. 
4568095) or 4-15%- (BIO-RAD #456-1083) Mini PROTEAN® gels in 
Tris/Glycine/SDS (BIO-RAD #1610772). Resolved proteins were transferred onto 
LF PVDF membrane, using the BIO-RAD TBT RTA kit and protocol using either 
10%MeOH or 20%EtOH-containing transfer buffer (cat. no. 1704272). PVDF 
membranes were incubated at 4°C overnight with appropriate primary antibodies 
in 1X TBS-T with 1.5% BSA. Primary antibodies included the following 
antibodies: b-Actin (Invitrogen, AM4302), H4 (CST, 2935), pERK (CST, 4370), 
Synapsin-I (SySy, 106011), PSD-95 (NeuroMab, 75-028). Next day, membranes 
were washed three times in 1X-TBST for 5 min each, probed with either goat-
anti-Mouse-647 or goat-anti-Rabbit-546 Alexa Fluor® secondary antibodies (Life 
Technologies) for 45 minutes at room temperature, washed three times with 1X 
TBS-T for 5 min each, and imaged using BIO-RAD Multiplex ChemiDocTM 
Imaging System.  
 
3.3.5 RNA extraction and gene transcription quantitation 
 
Total RNA was isolated from cultured neurons using the illustra RNAspin Mini kit 
(GE Lifesciences). Specific pre-mRNAs from these total RNA samples was 
initially amplified by cDNA synthesis (14 cycles) using Arc and Gapdh primers 
overlapping an intron-exon junction and a OneStep RT-PCR kit (Qiagen, 
#210212). Quantitative real-time PCR (qRT-PCR) was then performed from this 
cDNA to quantify levels of specific transcripts using iTaq Universal Sybr Green 
Supermix (BioRad) and the BIO-RAD CFX Connect realtime PCR Detection 
System. Fold-change from control was estimated using the delta-delta Ct 
method. 
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3.3.6 Drosophila rearing & chemical exposure 
 
Wild-type Canton-S Drosophila were maintained at 25°C on a standard cornmeal 
diet (Bloomington Drosophila Stock Center standard cornmeal medium). For oral 
administration of chemicals, PD0325901, BDE-47, 5-OH, and 6-OH were 
dissolved in dimethylsulfoxide (DMSO) and then added directly to warm food, 
prior to solidification. The concentration of DMSO was maintained at 0.02% for all 
exposures. Drosophila were exposed to PD at a concentration of 100nM. For all 
other chemicals (PBDE-47, 5-OH, and 6-OH), Drosophila were exposed to a 
concentration of 1uM. 
 
3.3.7 Fluorescence labeling and microscopy of Drosophila whole-mount brain 
preparations. 
 
Whole-mount immunostaining of adult brains was performed as described in 
Michel et al., 2004, except that brains were fixed for 25 minutes in 4% 
paraformaldehyde. Anti-Fasciclin II (FasII; monoclonal antibody ID4; 
Developmental Studies Hybridoma Bank, Iowa City, IA) was used at a 1:20 
dilution. Alexa488-conjugated goat anti-mouse secondary (Jackson 
ImmunoResearch, West Grove, PA) was used at a 1:1000 dilution. Images were 
captured using an Olympus laser scanning confocal microscope. 
 
3.3.8 Statistical analysis 
 
Error bars represent standard error of the mean throughout the article, except in 
Fig.7D where they represent 95% confidence intervals. Statistical analyses were 
conducted using GraphPad Prism 7 (GraphPad software, San Diego, CA). Data 
were analyzed by either one or two-way ANOVA with appropriate post-hoc tests 
for generation of specific P-values– either FDR correction method or LSD. The 
only exception is Fig.7D where the non-parametric Mann-Whitney U test was 
used to compare the medians of effect score distributions for the various 
treatment groups. Biological replicates are indicated throughout as N in 
corresponding figure legends. Biological replicates constitute cell culture 
preparations from the pooled cortices of embryos from independent litters or 
brains of individual flies. 
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3.4 Results 
 
3.4.1 Chronic 6-OH-BDE-47 exposure suppresses electrical activity in cortical 
neurons 
 
 We have previously shown that chronic exposure to nanomolar 
concentrations of 6-OH-BDE-47 (6-OH) impairs the ability of primary cortical 
neurons to induce transcription of the IEG Arc (Poston et al. 2018). Findings from 
that work indicated that the effects of the exposure were manifested at the level 
of synaptic functionality. To test this hypothesis directly, we utilized the same cell 
culture system, but grew cells on microelectrode arrays (MEAs). Cells were 
exposed to 500nM 6-OH from the day of plating. Spontaneous electrical activity 
of the networks were recorded daily (Fig. 1A). There were no obvious 
morphological differences in cell growth. We also previously demonstrated that 
this exposure level does not significantly impact cell viability (Poston et al. 2018). 
Spontaneous activity was detected usually starting at 6 days in vitro (DIV), which 
is consistent with previous reports for cultured cortical neurons (Charlesworth et 
al. 2015), and continued to the end of the experiment at DIV14. Networks 
exposed to 6-OH displayed significant suppression of spontaneous spiking 
Figure 3-1. Chronic 6-OH-BDE-47 exposure suppresses spontaneous neuronal activity and 
alters pre-synapses. Primary rat cortical neurons were grown on MEAs in order to assess the 
effects of 6-OH exposure on electrical activity. (A) Examples images of neurons at DIV10 
with or without exposure to 500nM 6-OH (left) example traces of recorded spontaneous 
activity (right) (B) Detectable activity was recorded and quantified through the first two weeks 
of growth in vitro, N=3-4. (C) Synaptosomes were isolated from DIV10 cultures. Pre-and 
post-synaptic markers were assessed by western blotting(left) densiometric quantification of 
blots (right), N=3-5. * indicates P-value <0.05. 
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across the recording period which was quantified and is summarized in Fig. 1B. 
To further clarify the synaptic nature of the exposure effects, we isolated 
synaptosomes from 6-OH treated cultures (DIV0-10) and evaluated levels of both 
pre- and post-synaptic protein markers by western blotting. We found a 
significant decrease in the amount of detectable Synapsin-I, but not PSD-95 (Fig. 
1C), indicating that 6-OH exposure likely imparts pre-synaptic dysfunction, 
although post-synaptic effects unrelated to PSD-95 cannot be ruled out. 
Together, these data support the hypothesis generated from our earlier work that 
chronic exposure to the BDE-47 hydroxylated metabolite, 6-OH, impairs synaptic 
composition and function.  
 
Next, we studied the effects of 6-OH on induced activity in neurons. This 
was partly to explain one of our previous observations where activity-induced 
expression of the IEG Arc was significantly reduced in networks exposed 
chronically to 6-OH (Poston et al. 2018). To test if chronic 6-OH exposure 
impaired firing patterns during induced activity – which could explain impaired 
Arc transcription – we evoked activity in unexposed and 6-OH exposed networks 
using two different bicuculline (Bic) stimulation paradigms (Fig. 2A). The first was 
continuous treatment with Bic, similar to the approach we previously used to 
induce Arc transcription (Poston et al. 2018). The other was a Bic stimulus 
Figure 3-2. Chronic 6-OH-BDE-47 exposure impairs evoked synaptic activity. Multiple 
stimulus paradigms were used to assess the effects of chronic 6-OH exposure on evoked 
electrical activity. (A) Graphical depiction of bicuculline stimulus paradigms. (B) Example of 
characteristic burst activity generate with Bic stimulus. (C&D) Quantification of spikes and 
bursts detected under continual Bic treatment, N=5-8. (E&F) Quantification of spikes and 
bursts detected after brief Bic stimulation and washout, N=3-8. * indicates P-value <0.05. 
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followed by washout, a treatment paradigm known to produce recurrent 
synchronous bursting that has been previously published as a model of in vitro 
plasticity (Arnold et al. 2005). Both types of Bic treatments produced 
characteristic burst firing patterns (Fig. 2B) that were diminished in 6-OH treated 
cells (Fig. 2C-F). The observed reduction in activity after 15 minutes of 
continuous Bic treatment (Fig. 2C, D) directly explains our earlier finding that 
chronic 6-OH exposure impairs activity-induced Arc transcription due to reduced 
firing of exposed neurons. The strong effect, seen under the Bic washout 
paradigm (Fig. 2E, F), further demonstrates the compromised synaptic 
functionality of 6-OH treated cells. 
 
3.4.2 6-OH-BDE-47 shares key structural features of non-ATP competitive type-
III MEK1 inhibitors 
 
 Next, we asked what cellular mechanism may underlie the 6-OH 
exposure-induced attenuation of neuronal activity. Because we have previously 
seen 1) 6-OH exposure inhibit transcription of IEG Arc (Poston et al. 2018), and 
2) MAPK signal transduction is required for Arc and other neuronal IEGs 
(Tyssowski et al. 2018), we wondered if 6-OH exposure may disrupt MAPK 
signaling. While closely inspecting 6-OH structure, we discovered that 6-OH 
shares key structural features with a class of kinase inhibitors that are 
commercially marketed as MEK1 inhibitors, a central kinase of the MAPK 
Figure 3-3. 6-OH-BDE-47 shares key structural features of non-ATP competitive type-III 
MEK1 inhibitors. (A) Chemical structures of the commercial MEK1 inhibitor PD0325901, 
BDE-47, and 6-OH-BDE-47 with key MEK-binding substituents highlighted. (B) Crystal 
structure of MEK1 (PDB: 3EQI) with top binding poses generated in ligand docking 
simulations for 6-OH and PD superimposed. (C) Rotated view of the allosteric binding 
pocket of MEK1 with most realistic generated poses of6-OH and PD. 
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pathway. It is thought that there are three key features that enable these specific 
small molecules to effectively inhibit MEK1, which are discussed at length 
elsewhere (Heald et al. 2012; Zhao et al. 2017b). Briefly, there are three major 
criteria: 1) a polar group that can engage the MEK1-Lys97, 2) a hydrogen bond 
acceptor to interact with MEK1-Ser212, and 3) a para-substituted ring opposite to 
the previous substituents that occupies a lipophilic pocket and interacts with 
MEK1-Val127– all of which 6-OH possesses (Fig. 3A).  
 
Given the importance of the MAPK pathway in neuronal activity-induced 
gene transcription (Tyssowski et al. 2018) and neuronal plasticity (Thomas and 
Huganir 2004), we hypothesized that the effects of 6-OH exposures discussed so 
far could be due to inhibition of the MAPK pathway. To test this hypothesis, and 
to gain insight into the plausibility of 6-OH binding to MEK1 as the small molecule 
inhibitor, we conducted Ligand-Protein docking simulations using published 
crystal structures of MEK1 and 6-OH as well as a commercial inhibitor, 
PD0325901 (PD). Utilizing AutoDock Vina (Trott and Olson 2010), which 
evaluated the  best binding poses for each ligand, we found that both 6-OH and 
PD were placed around the well-characterized binding pocket for this type of 
inhibitor, without the software having been given any prior knowledge of the 
binding surface. Almost all of the generated top poses for both 6-OH and PD 
clustered around this surface when the simulation was initialized near the 
catalytic kinase domain (Fig. 3B). The poses for 6-OH and PD that are closest to 
published binding modes of MEK1 inhibitors are superimposed in Fig. 3C. These 
results were encouraging and suggested that 6-OH is capable of interacting with 
the type of binding surface known to be targeted by small molecules specifically 
designed to inhibit MEK1. 
 
3.4.3 Chronic MEK1 inhibition by PD attenuates synaptic activity 
 
Informed by our in silico observations, we next asked if chronic PD 
treatment would mimic the effects of 6-OH chronic exposure on neuronal 
electrical activity (as in Fig. 1). We treated cortical neurons grown on MEAs with 
two mild doses of PD. As expected, both doses of PD significantly reduced 
spontaneous spiking across the recording period, which was quantified and is 
summarized in Figure 3-S1. This observation correlatively suggests that 6-OH 
may produce altered phenotypic outcomes – like, suppression of synaptic activity 
– via inhibition of the MAPK pathway. To test this hypothesis directly, we 
assessed the effects of acute 6-OH exposure in dissociated neurons in culture. 
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3.4.4 6-OH-BDE-47 inhibits MEK-ERK signaling in vitro  
 
 In mature neurons, MEK-ERK signaling conveys information from the 
membrane to many subcellular locations, including the synapse and the nucleus. 
To test the prediction that 6-OH is capable of directly inhibiting MEK1, and thus 
MEK-ERK signaling within cells, we acutely exposed primary cortical neurons to 
BDE-47 and its hydroxylated metabolites and then stimulated them with a 
treatment of Bic and 4AP. This treatment elevates intracellular calcium and 
induces the MEK-ERK signaling pathway, which may be read out as 
phosphorylation of ERK (pERK), the direct downstream target of MEK. We found 
that activity-induced cytosolic elevation of the pERK level was significantly 
reduced only in cells treated with 6-OH (Fig. 4A), but not the parent compound or 
other metabolites. While strong inhibition of pERK induction was observed with 
higher 6-OH concentrations, the lowest exposure level used (500nM) was 
ineffective. The 500nM dose, as we have previously estimated, is the 
approximate brain concentration reported from in vivo exposure studies of 
PBDEs in rodents (Poston et al. 2018) and is on the same order of magnitude as 
the EPA reported average for human exposure (U.S. Environmental Protection 
Agency (EPA) 2010). As we initially did not see a significant decrease in pERK 
levels with this environmentally-relevant concentration, we exposed cells to 
500nM 6-OH for increasing amounts of time, yielding qualitatively mild but not 
significant inhibition in the whole cell extract (Fig. 4B). Considering subcellular 
location-specific functions of the MEK-ERK pathway, we next prepared nuclear 
extracts from neurons treated with 500nM 6-OH to observe only the amount of 
Figure 3-S1. Chronic PD0325901 exposure suppresses spontaneous neuronal activity. 
Primary embryonic rat cortical neurons grown on MEAs were chronically exposed to low 
doses of PD0325901, starting at the time of plating, in order to assess whether exposure 
to a commercial MEK inhibitor would produce similar effects as prolonged 6-OH-BDE-47 
exposure. Detectable spontaneous activity was recorded and quantified across the first 
two weeks of growth in vitro, N=3. * indicates P-value <0.05, ** indicates P-value <0.01. 
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pERK entering the nucleus (Fig. 4C). Again, we observed mild reduction in pERK 
levels after acute exposure that was not significant after quantification. At this 
point, we rationalized that 500nM 6-OH may be too weak to detectably inhibit 
strong pERK levels induced by the 50mM Bicuculline treatment. To titrate the 
stimulus strength, we activated neurons with 5mM Bicuculline without 4AP. With 
a weaker stimulus, we found that acute exposure to 500nM 6-OH significantly 
decreased nuclear levels of pERK (Fig. 4D). Taken together, 6-OH inhibits the 
MAPK pathway in neurons in a dose- and stimulus strength-dependent manner. 
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Next, we measured pre-mRNA levels of the MAPK-dependent and neuron 
specific IEG Arc after acute PBDE exposure as a second approach to 
corroborate the above-mentioned pERK induction data. We acutely exposed 
neurons to BDE-47 and its hydroxylated metabolites as in Fig. 4A and found 
significant attenuation of Arc induction only after 6-OH exposure (Fig. 5B). To 
ensure that the observed effects were not solely caused by rapid feedback or 
effects at the synapse (on which the Bic/4AP treatment paradigm relies), we also 
stimulated cells with TTX and PMA. This treatment, which is previously described 
(Poston et al. 2018) and depicted in Fig. 5A, silences propagation of neuronal 
activity while activating MEK-ERK signaling likely through Protein Kinase-C  
(PKC). Again, we found that acute exposure only to 6-OH significantly attenuated 
Arc induction (Fig. 5C). Here the effect was not significant with a 500nM 
exposure, as with the cytosolic pERK data (Fig. 4), so we again examined 
whether the strength of the stimulus impacts the extent of inhibition by titrating 
the concentration of PMA the cells were treated with. As expected, we found that 
with a lighter stimulus, the extent of 6-OH-induced inhibition was greater, with Arc 
pre-mRNA levels significantly reduced when 6-OH exposed cells were stimulated 
with 0.1 and 0.01µM PMA (Fig. 5D). All together, these data suggest that the 
ortho-hydroxylated 6-OH, but not the parent compound or other metabolites, 
inhibits the MAPK pathway in neurons.  
  
Figure 3-4. (previous page) Acute 6-OH-BDE-47 exposure inhibits activity-dependent pERK 
levels. Activity-induced MEK-ERK signaling was assessed by measuring pERK levels by 
western blotting. (A) Cells acutely exposed to BDE-47 or one of its hydroxylated metabolites 
were stimulated with Bic/4AP for 10 minutes before collecting whole-cell lysates, N=4. (B) 
Cells were acutely exposed to the lowest exposure dose, 500nM, for increasing lengths of 
time before Bic/4AP stimulation and whole-cell lysate collection, N=3-6. (C) To assess 
nuclear availability of pERK after 6-OH exposure, nuclear lysates were collected after10 
minute Bic/4AP treatment, N=4-5. (D) Acute 6-OH exposed cells were treated with either 
Bic/4AP or a lower concentration of Bic by itself to assess the effect of stimulus strength on 
nuclear availability of pERK, N=3. * indicates P-value <0.05, ** indicates P-value <0.01. 
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Figure 3-5. Acute 6-OH-BDE-47 exposure attenuates activity and MEK-ERK 
dependent Arc transcription. MAPK-dependent gene transcription was evaluated as a 
measure of 6-OH mediated MEK-ERK inhibition by quantifying levels of Arc pre-mRNA 
following multiple stimulation approaches. (A) Graphical depiction of the stimulation 
methods used–Bic/4AP synaptically activates MEK-ERK signaling, while TTX/PMA 
suppresses neuronal activity while activating MEK via PKC. Both ultimately drive 
induction of Arc gene transcription. (B) Arc pre-mRNA levels were estimated following 
exposure to BDE-47 or one of its hydroxylated metabolites and treatment with Bic/4AP, 
N=3-5 (C) Similar to B, except that cells were stimulated with TTX/PMA, N=3-6. (D) To 
assess the effect of stimulus strength on inhibition of Arc induction by 6-OH. cells were 
acutely exposed to 500nM 6-OH before stimulus with a range of PMA concentrations, 
N=3-6. * indicates P-value <0.05, ** indicates P-value <0.01. 
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3.4.5 Specific ortho-hydroxylated PBDE metabolites inhibit MEK-ERK signaling in 
vitro 
 
 To further test the generality of our hypothesis regarding how hydroxylated 
PBDEs like 6-OH can inhibit MEK-ERK signaling, we acutely exposed cells to 
several other ortho-hydroxylated PBDE metabolites, whose possession or lack of 
the substituents thought to be critical for MEK inhibition are depicted in Fig. 6A. 
These include BDE-99, the second most environmentally prevalent PBDE 
humans are exposed to (U.S. Environmental Protection Agency (EPA) 2010). It 
was interesting to find that only one of these ortho-hydroxylates metabolites – 6-
OH-BDE-99 – reduced pERK induction following Bic treatment (Fig. 6B). This 
metabolite produced nearly an identical effect on Arc induction, at various 
concentrations, as 6-OH-BDE-47 (Fig. 5B & 6C). Together, our data suggests 
that for efficient MEK inhibition, ortho-hydroxylated PBDE metabolites require a 
para-substituted halogen on the same ring as the hydroxyl group (Fig. 6A), thus 
explaining why some ortho-hydroxylated metabolites and not others inhibit MEK 
and subsequent Arc transcription. 
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3.4.6 Axonal guidance is dysregulated in vivo by both 6-OH-BDE-47 and the 
MEK inhibitor PD0325901 
 
 Many developmental and functional processes in neurons are regulated 
by MAPK signaling (Samuels et al. 2009; Xing et al. 2016; Lyons and West 
2011). There is some evidence that MAPK signaling is involved in axonal 
guidance. One study reported that a let-60c mutation (a C. elegans ortholog of 
KRAS, a membrane GTPase upstream of MEK) led to axonal guidance defects 
manifested as aberrant ventral midline crossing (Bülow et al. 2004). Another 
confirmed that MEK-ERK signaling regulates netrin-1 dependent axonal 
branching in cultured hamster sensorimotor cortical neurons (Tang and Kalil 
2005). It has also previously been reported that primary hippocampal neurons 
exposed to BDE-47 and BDE-49 (and their hydroxylated metabolites) exhibited 
reduced axonal growth in vitro (Chen et al. 2017). To test the effects of 6-OH 
exposure in vivo in the context of MAPK inhibition, we exposed adult flies (D. 
Melanogaster) and their offspring to BDE-47, two of its hydroxylated metabolites, 
and PD. Then we assessed axonal guidance in the brains of offspring by 
observing effects on mushroom body ß-lobe axonal midline crossing. It may be 
noted that the amino acid sequence of MEK1 is highly conserved between H. 
Sapiens, R. Norvegicus, and D. melanogaster –– including the three key 
residues known to be involved in binding non-ATP competitive type-III inhibitors 
(Fig. 7A). In wild type Drosophila, ß-lobe axons do not or rarely cross the 
midline. However, under conditions that encourage abnormal axonal growth, 
these axons cross the midline to various degree (mild, moderate and severe). 
The qualitative scheme for assessing the extent of midline crossing is depicted in 
Fig. 7B and the frequency of the different effect severities are summarized in 
Fig. 7C. We found that 6-OH and PD exposure produced qualitatively similar 
increases in midline crossing, with more mild effects from BDE-47 and 5-OH-
BDE-47 (5-OH) exposures. This became more evident when the distribution of 
crossing frequencies was rank scored for each exposure and assessed 
quantitatively (Fig. 7D). Analysis of rank score revealed that 6-OH and PD shift 
the median effect from ‘none’ to ‘mild’ while the parent compound and 5-OH did 
not produce a significant change. These data indicate that 6-OH exposure can 
Figure 3-6. (previous page) Specific ortho-hydroxylated PBDE metabolites have the 
capacity to inhibit neuronal MEK-ERK signaling. In an effort to generalize our hypothesis 
that ortho-hydroxylated PBDE metabolites can inhibit MEK-ERK signaling, both 
approaches used to evaluate MEK inhibition by BDE-47 and its metabolites (Fig 4 and 5) 
were re-employed with several additional ortho-hydroxylated metabolites. (A) Chemical 
structures of PBDEs screened, with key substituents for potential MEK1 binding 
highlighted, specifically indicating the newly identified ortho-halogen thought to be critical 
for inhibition of MEK-ERK signaling. (B) Representative western blot measuring pERK 
levels after exposure to various PBDEs (top) with quantification of blots summarized 
(bottom), N=3 (C) Similar PBDE exposures as in B. but evaluating Arc pre-mRNA level 
attenuation by BDE-47 and BDE-99 metabolites, N=5. * indicates P-value <0.05, ** 
indicates P-value <0.01. 
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dysregulate axonal guidance in vivo and suggest that the effect may be mediated 
via inhibition of developmental MAPK signaling. 
 
 
 
 
 
Figure 3-7. In vivo exposure to 6-OH-BDE-47 and the MEK inhibitor PD0325901 disrupt 
axonal guidance. Canton-S flies (D. melanogaster) were exposed to BDE-47, 5-OH, 6-OH, or 
PD via feeding. The mushroom bodies of offspring were then assessed for aberrant midline 
crossing. (A) Alignment of the amino acid sequences of human Map2k1 (MEK1) and its rat 
and fly orthologs. The proteins are highly conserved, including the three key residues thought 
to mediate allosteric MEK1 inhibition. (B) Example images of the effect categories used in the 
qualitative scoring scheme. (C) Crossing frequency by severity level for each of the treatment 
groups, N=12-16. (D) Crossing severity was rank scored as follows: No crossing: 4, mild 
crossing: 3, moderate crossing: 2, severe crossing and/or lobe malformation: 1. The median 
score of each treatment group is displayed after applying a numerical scoring scheme. P-
values generated using the Mann-Whitney U test was used to compare the median of each 
group with that of the DMSO control, N=12-16. * indicates P-value <0.05. 
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3.5 Discussion 
 
PBDEs are well known environmentally pervasive toxins that are 
concerning for human health, especially considering the growing body of 
evidence linking their exposure levels to behavioral abnormalities related to 
NDDs. Much work has been done characterizing the effects and mechanisms of 
toxicity of PBDEs, but there is still not a clear general understanding of how 
these compounds compromise the developing nervous system and how the 
effects are related to adverse phenotypic outcomes. In this chapter, I propose a 
novel mechanistic hypothesis regarding how certain hydroxylated metabolites of 
common PBDEs (including BDE-47 and BDE-99) exert effects in neurons. Here, 
we corroborate earlier findings indicating that exposures to an ortho-hydroxylated 
BDE-47 metabolite, 6-OH, impacts synaptic functionality and extended those 
findings by showing that 6-OH exposure affects neurodevelopmental processes 
in vivo. We also, for the first time, demonstrate that specific ortho-hydroxylated 
metabolites can inhibit MEK-ERK signaling directly.  
 
From our previously published work, we had made two relevant 
predictions related to the effects of chronic 6-OH exposure: 1) effects in 
developing neurons likely manifest at the level of synaptic functionality and 2) 6-
OH may be capable of inhibiting signaling at or downstream of PKC (Poston et 
al. 2018). Primary cortical neuronal cultures grown on MEAs (Fig. 1&2) allowed 
us to directly test the first hypothesis. While some recent studies have begun to 
employ MEAs to study PBDE developmental neurotoxicity as part of larger 
screens (Brown et al. 2016; Frank et al. 2017; Shafer et al. 2019), the data 
presented here are, to our knowledge, the first example of such evidence for 
hydroxylated PBDE metabolite-induced effects. They demonstrate that chronic 
nanomolar 6-OH exposures suppress both spontaneous and evoked electrical 
activity and that the exposures specifically appear to impact pre-synaptic 
composition. Interestingly, 6-OH was found to have a pronounced effect on 
evoked activity under a Bic washout treatment paradigm, which has been 
previously published as a model of in vitro plasticity (Arnold et al. 2005). This 
may partially explain the reported relationship between learning deficits and 
BDE-47/99 exposure in animal studies (Dorman et al. 2018), as it is known that 
their hydroxylated metabolites can be produced endogenously, primarily via 
CYP2B6, which is known to be dynamically expressed in the brain (Malmberg et 
al. 2005; Lupton et al. 2009; Miksys and Tyndale 2004; Feo et al. 2013a; Erratico 
et al. 2013; Fu et al. 2016). 
 
In depth investigation of the second prediction generated from our 
previous work was spurred on by the serendipitous observation that 6-OH shares 
key chemical features with a class of inhibitors designed for MEK1, a central 
kinase in the MAPK signaling cascade (Plotnikov et al. 2011; Lyons and West 
2011). These inhibitors target an allosteric binding surface on MEK1, which has 
been well characterized due to interest in these compounds as drugs for cancer 
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therapy (Price 2008; Cheng and Tian 2017). The structural similarities and 
results from Ligand-Protein docking simulations encouraged us to pursue 6-OH 
as a potential MEK1 inhibitor (Fig. 3). Using multiple approaches to activate 
MEK-ERK signaling, mediated both synaptically and pharmacologically (Fig. 5A), 
we found that acute 6-OH exposures inhibit induction of pERK levels and MAPK-
regulated gene transcription (Fig. 4&5). Strong inhibition was found to be 
achieved at concentrations an order of magnitude higher than required with the 
commercial MEK inhibitor PD. This is consistent with the structure of 6-OH 
relative to PD, where 6-OH has a more minimal polar group that prevents 
additional interactions with MEK-bound ATP that further stabilize binding in the 
case of PD. Additionally, we found that time-of-exposure does not appear to 
increase the extent of inhibition by low concentrations of 6-OH (Fig. 4B) and that 
the strength of the stimulus driving MEK-ERK activation affects the extent of 6-
OH-mediated inhibition, with lighter stimuli leading to stronger inhibition for both 
the synaptic and PMA-driven MEK activation (Fig. 4D&5D). Overall, it is likely 
that environmentally relevant levels of MEK-inhibiting ortho-hydroxylated 
metabolites are not sufficient to widely suppress MAPK signaling throughout the 
cell (especially given the extensive negative feedback opposing perturbations), 
but they may regionally accumulate to high enough concentrations to inhibit MEK 
in specific subcellular locations, an interesting possibility that is further discussed 
below. 
 
In an effort to generalize our findings, we screened several other ortho-
hydroxylated metabolites of BDEs-68/99/123 and found that the metabolite of 
BDE-99 could also inhibit MEK-ERK signaling when used to acutely treat cells 
(Fig. 6). While initially surprising, these data indicate that in order for an ortho-
hydroxylated PBDE metabolite to be effective at inhibiting MEK-ERK signaling, it 
also specifically requires an ortho-substituted halogen that presumably interacts 
with MEK1 Ser212. Taken together, these several lines of molecular evidence 
demonstrate that specific ortho-hydroxylated PBDE metabolites can inhibit MEK-
ERK signaling in vitro. This potential for acute MEK-ERK inhibition, combined 
with chronic-exposure-induced deficits in synaptic activity and composition, 
corroborates and further explains our previous findings concerning the ability of 
cortical neurons to induce Arc expression following chronic 6-OH exposure 
(Poston et al. 2018).  
 
To validate our in silico and in vitro findings in vivo, we compared the 
exposure effects of PD to 6-OH using a neurodevelopmentally-relevant readout 
in fruit flies (D. melanogaster). Drosophila was chosen due to its relatively 
simplicity as an animal model and, importantly, the Drosophila ortholog of MEK1, 
Dsor1, is highly conserved– including the key amino acid residues that mediate 
allosteric inhibition (Fig. 7A). Further, it is known that MAPK signaling plays a 
role in developmental axon growth (Zhou and Snider 2006; Tang and Kalil 2005) 
and exposure to PBDEs have previously been reported to impact axonal growth 
in vitro(Chen et al. 2017). In our studies, exposure was accomplished via oral 
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administration to the P1 generation—to ensure embryonic exposure—and also to 
F1 larva to cover the neurodevelopmental period of the mushroom body 
formation. Adult offspring brains were examined immediately post-eclosion to 
assess the extent of mushroom body ß-lobe axonal midline crossing. Here, we 
found that 6-OH and PD exposures produced qualitatively similar increases in 
midline crossing, with BDE-47 and 5-OH also increasing crossing frequency, but 
to a lesser and insignificant extent (Fig. 7C). After applying a numerical scoring 
scheme and quantifying the effects, we found that 6-OH and PD shift the median 
effect to ‘mild’ while the parent compound and 5-OH did not produce a significant 
change. These data represent an in vivo confirmation of the effects of 6-OH 
exposure on axonal guidance and indicate that the effect may be mediated by 
MAPK signaling.  
 
While these findings strongly indicate for an inhibitory potential of these 
metabolites, we note some nuanced aspects of the observed effects. For 
example, cultures chronically exposed to 500nM 6-OH were able to synaptically 
induce cytosolic pERK to the same extent as untreated controls, while 
significantly less pERK was available in the nucleus (Fig. 4B&C). This was 
unexpected, especially given the compromised electrical activity observed for 
chronically treated cells, but could be explained by the extensive homeostatic 
feedback mechanisms known to be employed by the MAPK pathway (Lake et al. 
2016). Such feedback mechanisms may also explain the discrepancy between 
our findings and those of another recent report which showed that exposures to 
6-OH selectively inhibited ERK5 phosphorylation, but not ERK1/2, in adult neural 
stem cells (aNSCs) (Li et al. 2013). In this study the authors incubate aNSCs 
overnight with 5µM 6-OH, followed by a stimulus with EGF/bFGF to induced 
MAPK, and report no decrease in the amount of pERK1/2. In addition to the data 
from the present chapter showing that after prolonged treatment with 6-OH, 
cortical neurons induce the same level of pERK as untreated controls, it has 
been shown in mouse embryonic stem cells (ESCs) that acute PD treatment 
reduces pERK levels, but between 12 and 24 hours later, pERK signal strongly 
returns (Chen et al. 2015). Therefore, it is possible that either feedback within the 
MAPK pathway or differences in signaling dynamics in aNSCs account for this 
discrepancy between our observation and that by Li and colleagues.  
 
Interestingly, chronic 6-OH treatment-induced differences in cytosolic and 
nuclear pERK inhibition also suggest another nuanced aspect of PBDE toxicity: 
their sub-cellular localization and localized effects. Due to the highly lipophilic 
nature of PBDEs, they are likely to be more prominent within close proximity of 
membranes. Supporting this notion, it has been demonstrated that several 
PBDEs localize in higher amounts in mitochondrial and microsomal fractions 
collected from cerebral granule neurons (CGNs) (Huang et al. 2009). 
Accordingly, it will be interesting and necessary to evaluate the potential of ortho-
hydroxylated PBDE metabolites to inhibit specific pools of MEK, which is also 
known to be localized in different cellular compartments, including the cytosol, 
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mitochondria, outgrowing neurites and synapses (Wortzel and Seger 2011; Mao 
and Wang 2016). Considering the effects of such compartmentalized MEK 
inhibition may help to generally explain some of the various known effects of 
exposure to certain PBDEs, especially well-documented mitochondrial toxicity 
(Costa et al. 2014). Further, mitochondrial toxicity may link PBDE exposure to 
NDD etiology given the known comorbidity of mitochondrial deficits and autism 
(Wong and Giulivi 2016). Compartmentalized MEK inhibition could also be 
involved in the strong effect seen on Synapsin-I (Fig. 1C), as it and other 
synaptic proteins are known targets of synapse localized MAPKs (Yang et al. 
2017; Jovanovic et al. 1996). MAPK-Synapsin signaling is also known to play a 
role in pre-synaptic plasticity (Vara et al. 2009; Kushner et al. 2005; Cesca et al. 
2010; Giachello et al. 2010), which may be related to the effects of chronic 6-OH 
exposure on neuronal activity reported here (Fig. 1&2), though more work is 
needed for confirmation.  
 
Taken together, the findings presented here provide new evidence on the 
effects of exposure to hydroxylated PBDE metabolites and establish novel insight 
into the underlying molecular mechanisms that mediate their toxicity. The 
indication that PBDE metabolites are capable of inhibiting MEK-ERK signaling 
sets up several potential avenues for further investigation. One takes into 
account another aspect of our previously published work (Poston et al. 2018), 
that 6-OH exposure dysregulates expression of BAF chromatin remodeling 
subunits. This evidence, along with a recent preprint report concerning ERK1/2 
regulation of neurodevelopmental Polycomb Repressive Complex (PRC) 
chromatin remodeling that further speculates about additional regulation of BAF 
complex composition (Semprich et al. 2019), suggests that 6-OH exposure may 
interact with chromatin remodeling via modulation of MAPK signaling. More 
closely related to the data presented here, it will be critical to investigate the 
potential links between ortho-hydroxylated PBDE inhibition of MEK-ERK 
signaling and the many established routes of PBDE toxicity, especially related to 
mitochondrial function and regulation of synaptic proteins. Overall, such future 
studies may help to clarify the growing evidence linking human PBDE exposures 
to NDDs and perhaps provide useful insight into these debilitating disorders.  
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Chapter 4: Discussion and future directions–
Theory of developmental PBDE exposures and 
subcellular disruption of membrane bound 
structures as a general mechanism underlying 
toxicity of hydroxylated PBDE metabolites 
 
The body of work presented here has generated several novel findings 
regarding the toxicity of hydroxylated PBDE metabolites. Together, these findings 
support an intriguing model with which to generate and test further hypotheses 
regarding the general mechanisms of PBDE toxicity, the effects of these cellular 
disruptions in the nervous system, and the relationship of those effects to 
neurodevelopmental disorders. In this chapter, I will reiterate relevant 
characteristics and human exposure details of PBDEs, lay out both specific 
mechanistic details and a general working model of developmental PBDE 
exposures, and discuss new hypotheses generated considering this model and 
the novel findings presented in earlier chapters. 
 
Polybrominated diphenyl ethers are a class of organic small molecules 
with natural and anthropogenic sources. They were first patented for use as 
flame retardants in the 1960s and became heavily used in consumer products in 
the 1970s following introduction of legislation regarding fire safety, namely 
California’s Technical Bulletin 117 (TB117). The widespread use of PBDEs and 
that they are not chemically bound in consumer products has allowed them to 
leach into the environment, where they are now persistently stable and 
detectable around the globe. They also are known to accumulate in households, 
primarily in dust, leading to human exposures, particularly for infants and 
toddlers, who tend to have a higher body burden than adults (U.S. Environmental 
Protection Agency (EPA) 2010). In the human body, the lipophilicity of PBDEs 
leads to accumulation in lipid membranes, particularly in adipose tissue and the 
brain.  Transport into the brain is likely predominantly mediated by passive 
diffusion at multiple blood-brain interfaces, but may also be facilitated by the 
OATP family of thyroid hormone transporters (Pacyniak et al. 2010), allowing for 
facilitated crossing of the blood brain barrier (BBB) into astrocytes and the 
interstitial fluid and potential further trafficking into other neural cells (Schroeder 
and Privalsky 2014). Developmental exposures of the brain to PBDEs have been 
demonstrated to lead to defects in learning and memory in non-human animal 
studies and there is a growing body of evidence correlating exposure levels in 
humans to behavioral deficits related to NDDs (details and references in Chapter 
1). Accordingly, a large body of research has investigated the mechanisms of 
PBDE neurotoxicity, identifying several major mechanisms including: 
dysregulation of thyroid hormone signaling, interference with Ca2+ homeostasis, 
disruption of mitochondrial function leading to excess ROS and apoptosis, as 
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well as alterations to epigenetic regulation (Costa et al. 2014; Poston and Saha 
2019). Despite the progress that has been made, a clear understanding of the 
relationship between developmental PBDE exposures and observed behavioral 
deficits has not been achieved. Here I will present my working theory of 
developmental PBDE exposures and how their specific molecular and cellular 
effects may be related to NDDs, specifically integrating the findings generated 
from the experiments constituting the body of this thesis. 
 
4.1 Routes of neurodevelopmental PBDE exposures: barriers to the brain 
 
To understand the effects of PBDE exposure in the developing brain, a 
logical starting point is to first consider how and where these small organic 
molecules enter the brain. The theory and data on the topic of transport of 
various ions and molecules into the brain come from a variety of fields: early 
Figure 4-1. The protective barriers in the brain.  
Abbreviations: astro, astrocyte; bv, blood vessel; cpec, 
choroid plexus; csf, cerebrospinalfluid; peri, pericytes. From 
Stolp et al. 2013, used under Creative Commons license  
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physiological work characterizing the tissues of the nervous system, 
neurotoxicological studies concerned with the vulnerability of the developing 
nervous system, and also from research conducted in the context of the delivery 
of therapeutic drugs in the central nervous system, which may be a particularly 
useful framework for informing hypotheses on neurodevelopmental exposures to 
PBDEs and other persistent organic pollutants. From this wide body of work, it 
has been established that there are four main barriers in the developing brain: 
the blood-brain barrier (BBB, the interface between neural cells of the brain and 
the cerebral blood vessels), the blood-CSF barrier (BCSFB, the interface 
between blood vessels and the cerebral spinal fluid formed in the choroid plexus 
of each ventricle), the brain-CSF barrier (the meningeal barrier between the brain 
and the CSF in the subarachnoid space), and the fetal CSF-brain barrier (a 
temporary barrier in the fetal brain preventing free diffusion from the ventricular 
CSF to the brain) (Figure 4-1, from (Stolp et al. 2013)). These interfaces 
between blood, CSF, and brain allow tight control of the influx and efflux of ions, 
nutrients, proteins, etc., providing a highly regulated and protected environment 
in the brain. At each of the barriers, there are cellular structures of varying 
complexity, but all rely on a layer of epithelial cells with tight-junctions that 
prohibit free diffusion in the space between the cells, restricting transport to 
mechanisms involving movement across the surrounding cell membranes. 
Uniquely, at the BBB, the endothelial cells surrounding the cerebral vasculature 
are additionally wrapped in astrocytic processes called ‘astrocytic end-feet’, 
collectively referred to as the ‘neurovascular unit.’ The critical properties of these 
barriers are established early in development, despite the common notion that 
the fetal BBB is ‘immature’ (an idea that has persisted in the face of much 
evidence to the contrary (Ek et al. 2012; Johansson et al. 2008)). Additionally, 
the developing brain is further shielded by a barrier between the maternal and 
fetal bloodstream comprised of a layer of trophoblast cells connected by tight-
junctions, resembling the anatomy of the BCSFB at the choroid plexus (Metz et 
al. 1979).  
 
4.2 Passive diffusion: facilitation and hinderance 
 
Given the presence of the extensive barrier mechanisms in place 
protecting the developing brain, it would be natural to assume that it is relatively 
well protected from the influence of potentially toxic environmental insults. 
However, while these barriers are very efficient at regulating the transport of 
large macromolecules and even hydrophilic small molecules, it is much harder 
for them to exclude lipophilic small molecules (like PBDEs), whose movement 
across these barriers is theoretically limited only by their rate of diffusion across 
lipid membranes and re-partitioning back into the aqueous environment in cells 
or interstitial fluid. However, it is known that lipid diffusion of small molecules is 
limited by two key factors: their molecular weight (MW) and the number of 
hydrogen bonds they form. Typically it is held that the MW cutoff for efficient 
passive diffusion is in the range of 400 to 600 daltons (Da, 1:1 ratio with MW), 
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and that low numbers of hydrogen bonds facilitate lipid diffusion (Banks 2009; 
Pardridge 2012). A low degree of hydrogen bonding can also hinder the diffusion 
of small molecules, however, in that their partitioning back into aqueous milieus 
is deterred if they are too lipophilic. PBDEs (especially those with lower degrees 
of bromine substitution, tetra- and penta- congeners in particular) may possess 
an unfortunate balance with regard to these parameters, falling right within the 
400-600 MW range, and forming in the range of 4-10 hydrogen bonds, 
depending on their metabolic state, with hydroxylation by monooxygenases 
providing an additional 2 hydrogen bonds. Such hydroxylation of xenobiotics is 
known to be mediated by cytochrome P450 (CYP) enzymes, which are 
expressed in the brain, particularly in microvessels, choroid plexus, and 
meningeal membranes (Ghersi-Egea et al. 1994), with CYP1B1 expression 
predominating in the microvessels (Dauchy et al. 2008). In fact, metabolism by 
CYPs is known to be a mechanism by which the BBB and BCSFB limit the 
passive diffusion of lipophilic small molecules by transforming them into typically 
less active forms that are more readily effluxed from barrier epithelial cells by 
transporters that will be detailed below (Strazielle and Ghersi-Egea 2013). 
Hydroxylation by CYPs would promote protective efflux of PBDEs diffusing into 
epithelial barrier cells, however, PBDEs are predominantly metabolized by 
CYP2B6 (Feo et al. 2013b), which has been detected in the brain (Gervot et al. 
1999), but is only known to be expressed in neurons and astrocytes, including 
astrocytes surrounding cerebral blood vessels (Miksys et al. 2003). Thus, PBDEs 
may be capable of bypassing the protective mechanism of CYP-mediated 
metabolism at most of the various brain barriers and may be converted into 
hydroxylated metabolites with increased toxicity in astrocytes and neurons. 
 
Transporters with a preference for metabolized substrates are not the only 
means of xenobiotic efflux. The barrier forming epithelial cells of the brain and 
placenta express a diverse class of membrane transporters known as ATP-
binding cassette (ABC) efflux transporters. ABC-transporter expression is known 
to robustly restrict the entry of lipophilic xenobiotics in the adult brain, but while 
expression has been confirmed in the barrier cells of the developing and 
newborn brain, the functional degree of efflux efficiency has not been determined 
(Saunders et al. 2012; Ek et al. 2012). The main transporters involved in barrier 
forming cells are p-Glycoprotein (P-gp), which intercepts lipophilic molecules 
while they are crossing the cell membrane, and two others that primarily efflux 
intracellular metabolized substrates, breast cancer resistance protein (BRCP) 
and multidrug resistance related proteins (MRPs). Concerningly, there is 
evidence that PBDEs may not be good substrates for two of these predominant 
ABC-transporters, P-gp and BRCP. The study reporting these findings utilized 
artificial human vesicles with embedded P-gp and BRCP from which they could 
determine the internal concentration of BDE-47 and 6-OH-BDE-47 following 
exposure of the vesicles to the compounds (Marchitti et al. 2017). They found 
that the rate of uptake of the PBDEs was independent of the presence of ATP, 
which is necessary for the transporters to function. This suggests that both the 
62 
 
compounds are likely weak substrates for the transporters and that both are 
capable of appreciably crossing lipid membranes by passive diffusion. Another 
finding from the same and an additional study, show that BDE-47 and 6-OH-
BDE-47 inhibit P-gp and BRCP activity, though only at relatively high 
concentrations (Nicklisch et al. 2016; Marchitti et al. 2017). Therefore, two of the 
main ABC-transporters preventing lipophilic small molecules from entering the 
brain (P-gp and BRCP) may be relatively ineffective in the case of unmodified 
and hydroxylated PBDEs (at least for BDE-47 and 6-OH-BDE-47), while BCRP- 
and MRP-mediated efflux of PBDEs may be avoided by the apparent lack of 
CYPs capable of mediating PBDE metabolism (though they would still be 
protective in the case of hydroxylated metabolites entering from the 
bloodstream). Given these data, and the well-documented vulnerability of the 
brain’s barriers to small lipophilic molecules, it may be the case that PBDEs can 
relatively easily passively diffuse into the brain from the bloodstream at the 
interfaces described above (Figure 4-1).  
 
While the lipophilicity of PBDEs may contribute to their ability to passively 
diffuse across the brain’s restrictive epithelial cell barriers, it also limits the 
distance the compounds can efficiently spread by diffusion once in the cell-dense 
brain, which logarithmically decreases by a factor of approximately 10 for each 
500µm from the point of entry (Fung et al. 1996). This indicates that PBDEs 
diffusing into the brain should tend to accumulate at the highest concentrations in 
cells surrounding points of contact with the CSF (i.e. cells proximal to the 
ventricles and other CSF-contacting surfaces of the brain, though for the latter, 
the CSF-brain barrier would have to be crossed) and with the cerebral 
vasculature (especially astrocytes contributing to the neurovascular unit). The 
number and distribution of cells thereby exposed to PBDEs would grow over the 
course of development, with choroid plexus and therefore CSF-proximal 
exposures highest at earlier stages of development relative to CSF-distal cells, 
depending on the ratio of CSF- to vasculature-exposed tissue (Saunders et al. 
2012). With time, the increasing extent of vascularization and ventricular surface 
area would increase exposures, while the CSF concentration of PBDE and thus 
exposure level of ventricle-proximal cells would decrease as CSF volume 
increases so long as exposure levels of PBDE remained constant. The 
assumption that PBDE levels would remain constant across development is 
somewhat unrealistic, however, especially given the heightened exposure levels 
documented for young children, whose exposure level likely increases during 
early post-natal life due to higher rates of exposure to PBDEs in household dust 
and breastmilk (U.S. Environmental Protection Agency (EPA) 2010).  
 
4.3 Active transport: thyroid hormone displacement 
 
In addition to PBDEs entering the brain by passive diffusion, it appears 
that their crossing of the BBB can be facilitated by binding to the organic anion 
transporter polypeptide (OATP) family of thyroid hormone transporters given 
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several pieces of evidence. While thyroid hormones were long assumed to 
passively diffuse into the brain, they are now believed to be actively transported 
across the BBB by OATP transporters (Suzuki and Abe 2008). Recently, it has 
been demonstrated that several hepatic OATP transporters mediate PBDE 
uptake in liver, including OATP2B1 (Pacyniak et al. 2010), which has been found 
to be highly expressed in brain capillaries, suggesting a specific role in 
transporting thyroxine (T4) across the BBB (Gao et al. 2015). Given these data, it 
seems that PBDEs are likely actively transported across the BBB into astrocytes 
and the interstitial fluid and potentially further trafficked into other neural cells via 
additional transporters, potentially including neuron-localized OATPs (Schroeder 
and Privalsky 2014; Gao et al. 2015). The addition of active transport and 
trafficking through neural cells to the passive diffusion capabilities of PBDEs 
widens their potential reach in the brain and suggests that exposure level of cells 
surrounding the cerebral vasculature may be higher than would be expected from 
PBDE diffusion alone. 
 
4.4 Summary of tissue level exposure  
 
In summary, the model I propose here is that PBDEs enter the developing 
nervous system by a combination of passive diffusion and active transport, with 
the predominant sites of entry likely at points of CSF contact and via the cerebral 
vasculature. PBDEs that have not been metabolized are likely more capable of 
crossing the various brain barriers but are also potentially metabolized by 
CYP450s into more toxic hydroxylated metabolites in astrocytes and neurons. 
During pre-natal development, exposure would depend on the level of PBDEs in 
maternal blood and the extent to which they can cross the placental and 
developmental brain barriers. At earlier stages of neurodevelopment, crossing of 
PBDEs from the fetal blood into the CSF via choroid plexus would account for 
most of the exposure, while over time, increasing cerebral vascularization would 
lead to further exposure. After birth, the loss of the placental barrier, coupled with 
high rates of PBDE intake from dust and breastmilk may be responsible for the 
observed high PBDE levels. Ongoing neurodevelopmental processes during this 
period, such as axonal/dendritic outgrowth, synaptogenesis, and myelination may 
be at particular risk for disruption, though it is difficult to speculate on the relative 
vulnerability of the many critical processes at work across early brain 
development. With time and growth, subsiding exposure levels and a maturing 
brain likely lead to a reduction in PBDE-associated toxicity risk in the nervous 
system. This model realistically depends on additional parameters that are 
dynamic over the course of neurodevelopment, such as changing properties  of 
the cells making up the various brain barriers (particularly expression of 
transporter proteins), the influence of the loss of placental protection at birth 
relative to the newborn’s own blood filtering capabilities, rates of CSF clearance 
relative to PBDE influx, increasing blood volume relative to exposure level, etc. 
However, it provides a reasonable framework for generating hypotheses 
concerning neurodevelopmental PBDE exposures, given the likely mechanisms 
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and routes of PBDE entry. For example, based on this exposure model and 
considering the potential for some hydroxylated PBDE metabolites to inhibit 
MAPK signaling (see Chapter 3), I developed a series of experiments to test the 
effects of PBDEs to affect CSF-proximal cells in the developing brain. After 
injecting BDE-47 and 6-OH-BDE-47 into the lateral ventricles of embryonic rats, 
markers of neuronal differentiation can be monitored to detect effects on the pool 
of radial glial cells (RGCs, the progenitor cells from which cortical neurons are 
derived) surrounding the ventricles that would be most heavily exposed to 
PBDEs in the CSF. In particular, Tbr2, a marker of intermediate progenitor cells 
(differentiated RGCs migrating into the forming cortex) can be used given that it 
has been reported that pharmacological inhibition of MEK-ERK signaling in the 
developing brain led to an increased number of Tbr2 positive cells (Rhim et al. 
2016). Markers for additional cell populations derived from exposed RGCs at the 
ventricles further allow for monitoring of potential PBDE-induced effects. Some 
example images are shown here (Figure 4-2), while quantitative results from 
initial experiments remain preliminary. At present it does not appear that there is 
a striking difference when several PBDEs were injected at a level of 500nM. This 
experiment illustrates, however, how hypotheses can be informed by both the 
developmental exposure model I describe here and known molecular effects of 
PBDEs. It will be interesting to further investigate the effects of PBDEs injected in 
utero on other neurodevelopmental processes (including axonal guidance, 
particularly in axon-dense regions close to the CSF, see results from Chapter 3) 
and CSF-proximal cells, especially given the control of exposure level and timing 
afforded by this approach. Studies aimed at testing the effects of PBDE exposure 
on cells near the cerebral vasculature can additionally be conducted, but would 
be more practically achieved utilizing either feeding of the compounds or 
injections outside of the brain preceding and throughout developmental stages at 
which cerebral vascularization is becoming prominent. 
 
 
 
Figure 4-2. Monitoring the developing cortex in vivo. Coronal sections of embryonic day 18 rat 
brains.  Example images are from unexposed controls from the in utero PBDE injection 
experiments described here. Markers of various cell populations relevant to cortical development 
are indicated. H3- histone 3; Tbr2- T-box brain protein 2 or eomesodermin; NeuN- Rbfox3 
(originally referred to as antigen for “Neuronal Nuclei”) 
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4.5 Cellular PBDE exposure: the importance of sub-cellular distribution 
 
In addition to the tissue-level exposure model detailed thus far, 
considering the cellular fates of PBDEs that make it into the brain is imperative 
for understanding their toxicity. The lipophilic nature of PBDEs that I have 
discussed as a major factor influencing their entrance into the brain likely also 
dictates how they behave in neural cells. PBDEs, once past the barriers of the 
brain, are free to diffuse throughout the interstitial fluid and into cells they come 
into contact with. They may also be actively trafficked in a manner similar to 
thyroid hormones. It is important to note here that it is thought that the presence 
of PBDEs in neural cells may exert either direct effects or indirectly influence 
exposed and surrounding cells by disrupting thyroid hormone homeostasis and 
signaling (Dingemans et al. 2011). In this body of work, I have largely focused on 
investigating direct, non-thyroid hormone related effects, and will continue that 
focus in the discussion here. By either diffusion or trafficking, once PBDEs come 
to reside in a neural cell, their lipophilicity should lead to their accumulation in the 
various membranes of these cells, including membrane bound organelles. This 
has been found to be the case in a study of PBDE accumulation in cerebellar 
granule neurons that reports the highest levels of accumulation of tested PBDEs 
in the microsomal (vesicles-like artifacts of cell lysis formed from membranes, 
largely from the endoplasmic reticulum) and mitochondrial fractions (Huang et al. 
2010). Results from this study that have also been reported elsewhere highlight 
another important aspect of the kinetics of cellular PBDE accumulation– that 
PBDEs rapidly accumulate in cells and appear to magnify in concentration over 
time, sometimes to levels orders of magnitude higher than the concentration they 
are exposed to (Mundy et al. 2004; Kodavanti et al. 2005; Huang et al. 2009). 
This trend suggests that PBDEs may accumulate in exposed cells to higher 
concentrations than detected in the blood, perhaps even in a sub-cellular specific 
manner in and around membranes and membrane bound organelles. It also 
suggests that reports of brain concentrations of PBDEs from tissue may 
underestimate the levels that are actually present in specific sub-cellular 
locations, which could be modeled and directly tested going forward. Aside from 
the issue of the concentration of accumulating PBDEs in neural cells, the 
combination of available experimental observations and theoretical inferences 
regarding the intracellular distribution and kinetics of PBDEs presented here 
support the notion that PBDEs accumulate in a sub-cellular specific manner in 
and around membrane bound cellular structures. I believe this will be a critical 
concept for generating future hypotheses towards a more complete 
understanding of the effects of PBDEs in the developing nervous system and 
their relation to NDDs. With this in mind, I will close this chapter by briefly 
discussing the novel findings presented here within the context of the 
neurodevelopmental exposure and sub-cellular distribution models detailed 
above. 
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Taking into account the sub-cellular distribution of PBDEs and 
acknowledging their proclivity for accumulation in membrane bound structures 
may go a long way towards understanding some of the findings presented here 
and the known effects of PBDE exposures. Unmetabolized PBDEs entering the 
developing brain in the manner described in this chapter would most heavily 
accumulate in the membrane bound organelles of cells proximal to the CSF and 
to the cerebral vasculature. These would include astrocytes participating in 
neurovascular units and any cells close to the outer surfaces of brain regions 
bathed in CSF and proximal to the ventricles. Little is known about the effects of 
PBDEs in astrocytes– given that they may be some of the most directly and 
heavily exposed cells in the brain, future studies should explore potential effects 
in astrocytes. PBDEs accumulating in exposed neurons and astrocytes, 
especially in their mitochondria and endoplasmic reticuli, would be potentially 
subject to metabolism by CYP450 enzymes, producing hydroxylated metabolites 
with higher potential for toxicity. This process would be exacerbated by the high 
number and activity of mitochondria required to sustain the energetically 
demanding neurons. Thus, regions of high parent compound concentration may 
facilitate relatively high concentrations of hydroxylated PBDE metabolites.  
 
4.6 New hypotheses and future directions 
 
As shown in Chapter 3, certain hydroxylated metabolites seem to be 
capable of inhibiting MEK-ERK signaling. High levels of hydroxylated metabolites 
in neuronal mitochondria may therefore specifically disrupt MEK-ERK signaling in 
and around the organelles. This is an intriguing notion, as there is a growing 
appreciation for sub-cellular localization mediating specific MEK-ERK functions, 
and for the complex activation and trafficking of distinct pools of MAPKs between 
the cytosol, mitochondria, and nucleus (Alonso et al. 2004; Wortzel and Seger 
2011). This complex trafficking has recently been shown to be sensitive to redox 
conditions including concentrations of hydrogen peroxide (Helfenberger et al. 
2018). Reduced MEK-ERK signaling in neurons may further harm neuronal 
mitochondria by a mechanism involving activity-induced transcription of a MEK-
ERK dependent gene, Npas4. Npas4 is an activity-induced transcription factor 
that has been shown to repress the mitochondrial calcium uniporter (Mcu) during 
periods of elevated activity, thus preventing Ca2+ overload and toxicity in 
mitochondria (Qiu et al. 2013).  Taken together, these data indicate that PBDE-
induced disruption of MEK-ERK signaling may be connected to the well-known 
effects of PBDEs on disruption of mitochondria and their redox processes. A 
natural continuation of the work presented in this dissertation would be to explore 
the potential connection between mitochondrial PBDEs, MEK-ERK signaling, and 
mitochondrial dysfunction, including isolating neuronal mitochondria for 
experiments involving exposure to hydroxylated PBDEs. Another future direction 
is to explore the potential accumulation of PBDEs in neuronal pre-synapses, 
which undergo a high rate of membrane turnover and contain a large number of 
membrane bound structures–synaptic vesicles. Data from Chapter 3 suggest that 
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pre-synapses and axonal guidance are affected by hydroxylated PBDEs. This 
may be due to the large number of vesicles and high rate of membrane turnover 
present in pre-synapses and axonal growth cones. A specific point of disruption 
may again be MEK-ERK signaling, particularly in regulating synapsin dynamics, 
a well-known MAPK regulated protein involved in pre-synaptic physiology (Cesca 
et al. 2010). Finally, PBDE-induced MEK-ERK and mitochondrial disruption may 
also be connected to the observed epigenetic effects of PBDE exposure. There 
is a growing body of evidence connecting mitochondrial dysfunction to alterations 
in nuclear DNA methylation (reviewed elsewhere (Minocherhomji et al. 2012))– 
the most extensively studied epigenetic disruption of PBDE exposure. Altered 
neuronal MEK-ERK signaling may also be related to the finding reported here in 
Chapter 2 concerning PBDE-exposure induced dysregulation of BAF complex 
subunit expression. Little is known about the transcriptional mechanisms 
regulating the expression of BAF complex subunits, and MAPK signaling is 
possibly involved. This idea is supported by a recent preprint report detailing the 
role of ERK signaling in the eviction of PRC complexes from neural genes 
(Semprich et al. 2019) and by the known role of the BAF complex in evicting 
PRC from heterochromatin (Kadoch et al. 2017). It appears that declining ERK 
signaling leads to the irreversible eviction of PRC complexes from neural genes, 
which I propose may be due to alterations in ERK-regulated BAF complex 
subunit expression that affects the ability of BAF to evict PRC complexes. Study 
of the roles of PBDE-disrupted MEK-ERK signaling in regulating such BAF 
subunit transcription is another future direction generated from the work 
presented here, and the last that I will discuss. 
 
Going forward, I hope that this body of work will be of value in continuing 
to build an understanding of the effects of PBDE exposures in the developing 
nervous system, how these exposures are related to observed behavioral deficits 
in animals, generating insight regarding the interplay between genetic and 
environmental risk factors in neurodevelopmental disorders, and, generally, in 
appreciating the fascinating interconnected nature of molecular and cellular 
processes in the nervous system that act as the biological substrates of 
information processing underlying its ability to generate, perceive, and know. 
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